Triggering	O
of	O
HLA-DR	B-protein
antigens	I-protein
differentially	O
modulates	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
release	O
by	O
B	B-cell_type
cells	I-cell_type
at	O
distinct	O
stage	O
of	O
maturation	O
.	O

Triggering	O
of	O
HLA	B-protein
class	I-protein
II	I-protein
antigens	I-protein
by	O
the	O
anti-HLA-DR	B-protein
monoclonal	I-protein
antibody	I-protein
(	I-protein
mAb	I-protein
)	I-protein
L243	I-protein
significantly	O
(	O
P	O
<	O
0.05	O
)	O
and	O
differentially	O
enhanced	O
the	O
release	O
of	O
tumor	B-protein
necrosis	I-protein
factor	I-protein
alpha	I-protein
(	O
TNF-alpha	B-protein
)	O
by	O
the	O
non-Hodgkin	B-cell_type
's	I-cell_type
lymphoma	I-cell_type
cells	I-cell_type
Ri-I	B-cell_line
,	O
Ci-I	B-cell_line
,	O
and	O
Sc-I	B-cell_line
,	O
which	O
are	O
at	O
a	O
distinct	O
stage	O
of	O
B-cell	O
differentiation	O
,	O
and	O
by	O
the	O
more	O
mature	O
Burkitt	B-cell_line
lymphoma	I-cell_line
cell	I-cell_line
Raji	I-cell_line
;	O
in	O
contrast	O
,	O
it	O
did	O
not	O
induce	O
TNF-alpha	B-protein
release	O
by	O
the	O
pre-B	B-cell_type
leukemia	I-cell_type
cells	I-cell_type
Nalm-6	B-cell_line
and	O
BV173	B-cell_line
.	O

TNF-alpha	B-protein
release	O
peaked	O
at	O
24	O
h	O
and	O
decreased	O
thereafter	O
,	O
and	O
it	O
was	O
dose	O
dependent	O
and	O
preceded	O
by	O
an	O
increase	O
of	O
TNF-alpha	B-RNA
mRNA	I-RNA
detectable	O
after	O
3	O
h	O
of	O
stimulation	O
with	O
mAb	B-protein
L243	I-protein
.	O

Secreted	O
TNF-alpha	B-protein
mediated	O
the	O
enhancement	O
of	O
nuclear	B-protein
factor	I-protein
kappa	I-protein
B	I-protein
(	O
NF-kappa	B-protein
B	I-protein
)	O
and	O
activator	O
protein-1	O
(	O
AP-1	B-protein
)	O
binding	O
activity	O
;	O
in	O
fact	O
,	O
the	O
triggering	O
of	O
HLA-DR	B-protein
antigens	I-protein
in	O
the	O
presence	O
of	O
antihuman	B-protein
TNF-alpha-neutralizing	I-protein
antibodies	I-protein
did	O
not	O
upregulate	O
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
.	O

In	O
contrast	O
,	O
released	O
TNF-alpha	B-protein
was	O
not	O
responsible	O
for	O
the	O
homotypic	O
aggregation	O
of	O
Ri-I	B-cell_line
,	O
Ci-I	B-cell_line
,	O
Sc-I	B-cell_line
,	O
and	O
Raji	B-cell_line
cells	I-cell_line
induced	O
by	O
mAb	B-protein
L243	I-protein
,	O
and	O
it	O
did	O
not	O
affect	O
the	O
proliferation	O
of	O
B	B-cell_type
cells	I-cell_type
investigated	O
.	O

Altogether	O
,	O
our	O
data	O
demonstrate	O
that	O
:	O
(	O
a	O
)	O
the	O
ability	O
of	O
B	B-cell_type
cells	I-cell_type
to	O
release	O
TNF-alpha	B-protein
after	O
triggering	O
of	O
HLA-DR	B-protein
antigens	I-protein
depends	O
on	O
their	O
stage	O
of	O
differentiation	O
;	O
(	O
b	O
)	O
levels	O
of	O
released	O
TNF-alpha	B-protein
seem	O
to	O
correlate	O
with	O
the	O
stage	O
of	O
B-cell	O
maturation	O
but	O
do	O
not	O
correlate	O
with	O
the	O
amounts	O
of	O
cell	B-protein
surface	I-protein
HLA-DR	I-protein
antigens	I-protein
;	O
(	O
c	O
)	O
secreted	O
TNF-alpha	B-protein
regulates	O
the	O
levels	O
of	O
expression	O
of	O
NF-kappa	B-protein
B	I-protein
and	O
AP-1	B-protein
by	O
an	O
autocrine	O
loop	O
;	O
and	O
(	O
d	O
)	O
intracellular	O
signals	O
mediating	O
TNF-alpha	B-protein
release	O
by	O
B	B-cell_type
cells	I-cell_type
are	O
distinct	O
from	O
those	O
regulating	O
homotypic	O
aggregation	O
and	O
proliferation	O
.	O

Vol	NULL
.	NULL

8	NULL
,	NULL
581-588	NULL
,	NULL
May	NULL
1997	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Triggering	NULL
of	NULL
HLA-DR	NULL
Antigens	NULL
Differentially	NULL
Modulates	NULL
Tumor	NULL
Necrosis	NULL
Factor	NULL
a	NULL
Release	NULL
by	NULL
B	NULL
Cells	NULL
at	NULL
Distinct	NULL
Stage	NULL
of	NULL
Maturation	NULL
'	NULL
Sandra	NULL
Coral	NULL
,	NULL
Carlo	NULL
Pucillo	NULL
,	NULL
Antonio	NULL
Leonardi	NULL
,	NULL
Ester	NULL
Fonsatti	NULL
,	NULL
Maresa	NULL
Altomonte	NULL
,	NULL
and	NULL
Michele	NULL
Maio*	NULL
Advanced	NULL
Immunotherapy	NULL
Unit	NULL
,	NULL
Centro	NULL
di	NULL
Riferimento	NULL
Oncologico	NULL
,	NULL
istituto	NULL
di	NULL
Ricovero	NULL
e	NULL
Cura	NULL
a	NULL
Carattere	NULL
Scientifico	NULL
,	NULL
33081	NULL
Aviano	NULL
,	NULL
Italy	NULL
[	NULL
S.	NULL
C.	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
M.	NULL
M.	NULL
]	NULL
,	NULL
and	NULL
Department	NULL
of	NULL
Sciences	NULL
and	NULL
Biomedical	NULL
Technologies	NULL
,	NULL
University	NULL
of	NULL
Udine	NULL
,	NULL
33100	NULL
Udine	NULL
,	NULL
Italy	NULL
[	NULL
C.	NULL
P.	NULL
,	NULL
A.	NULL
L.	NULL
]	NULL
Abstract	NULL
Triggering	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
by	NULL
the	NULL
anti-HLA-DR	NULL
monoclonal	NULL
antibody	NULL
(	NULL
mAb	NULL
)	NULL
L243	NULL
significantly	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
and	NULL
differentially	NULL
enhanced	NULL
the	NULL
release	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor	NULL
«	NULL
(	NULL
TNF-a	NULL
)	NULL
by	NULL
the	NULL
non-Hodgkin	NULL
's	NULL
lymphoma	NULL
cells	NULL
Ri-1	NULL
,	NULL
Ci-l	NULL
,	NULL
and	NULL
Sc-l	NULL
,	NULL
which	NULL
are	NULL
at	NULL
a	NULL
distinct	NULL
stage	NULL
of	NULL
B-cell	NULL
differentiation	NULL
,	NULL
and	NULL
by	NULL
the	NULL
more	NULL
mature	NULL
Burkitt	NULL
ymphoma	NULL
cell	NULL
Raji	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
it	NULL
did	NULL
not	NULL
induce	NULL
TNF-a	NULL
release	NULL
by	NULL
the	NULL
pre-B	NULL
leukemia	NULL
cells	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
.	NULL

TNF-a	NULL
release	NULL
peaked	NULL
at	NULL
24	NULL
h	NULL
and	NULL
decreased	NULL
thereafter	NULL
,	NULL
and	NULL
it	NULL
was	NULL
dose	NULL
dependent	NULL
and	NULL
preceded	NULL
by	NULL
an	NULL
increase	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
detectable	NULL
after	NULL
3	NULL
h	NULL
of	NULL
stimulation	NULL
with	NULL
mAb	NULL
L243	NULL
.	NULL

Secreted	NULL
TNF-a	NULL
mediated	NULL
the	NULL
enhancement	NULL
of	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
(	NULL
NF-	NULL
«	NULL
B	NULL
)	NULL
and	NULL
activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
binding	NULL
activity	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
antihuman	NULL
TNF-a	NULL
«	NULL
-neutralizing	NULL
antibodies	NULL
did	NULL
not	NULL
up-regulate	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
released	NULL
TNF-a	NULL
was	NULL
not	NULL
responsible	NULL
for	NULL
the	NULL
homotypic	NULL
aggregation	NULL
of	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
induced	NULL
by	NULL
mAb	NULL
L243	NULL
,	NULL
and	NULL
it	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
proliferation	NULL
of	NULL
B	NULL
cells	NULL
investigated	NULL
.	NULL

Altogether	NULL
,	NULL
our	NULL
data	NULL
demonstrate	NULL
that	NULL
:	NULL
(	NULL
a	NULL
)	NULL
the	NULL
ability	NULL
of	NULL
B	NULL
cells	NULL
to	NULL
release	NULL
TNF-a	NULL
«	NULL
after	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
depends	NULL
on	NULL
their	NULL
stage	NULL
of	NULL
differentiation	NULL
;	NULL
(	NULL
b	NULL
)	NULL
levels	NULL
of	NULL
released	NULL
TNF-	NULL
«	NULL
seem	NULL
to	NULL
correlate	NULL
with	NULL
the	NULL
stage	NULL
of	NULL
B-cell	NULL
maturation	NULL
but	NULL
do	NULL
not	NULL
correlate	NULL
with	NULL
the	NULL
amounts	NULL
of	NULL
cell	NULL
surface	NULL
HLA-DR	NULL
antigens	NULL
;	NULL
(	NULL
c	NULL
)	NULL
secreted	NULL
TNF-a	NULL
regulates	NULL
the	NULL
levels	NULL
of	NULL
expression	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
by	NULL
an	NULL
autocrine	NULL
loop	NULL
;	NULL
and	NULL
(	NULL
d	NULL
)	NULL
intracellular	NULL
signals	NULL
mediating	NULL
TNF-a	NULL
release	NULL
by	NULL
B	NULL
cells	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
regulating	NULL
homotypic	NULL
aggregation	NULL
and	NULL
proliferation	NULL
.	NULL

Received	NULL
11/4/96	NULL
;	NULL
accepted	NULL
1/29/97	NULL
.	NULL

The	NULL
costs	NULL
of	NULL
publication	NULL
of	NULL
this	NULL
article	NULL
were	NULL
defrayed	NULL
in	NULL
part	NULL
by	NULL
the	NULL
payment	NULL
of	NULL
page	NULL
charges	NULL
.	NULL

This	NULL
article	NULL
must	NULL
therefore	NULL
be	NULL
hereby	NULL
marked	NULL
advertisement	NULL
in	NULL
accordance	NULL
with	NULL
18	NULL
U.S.C	NULL
.	NULL

Section	NULL
1734	NULL
solely	NULL
to	NULL
indicate	NULL
this	NULL
fact	NULL
.	NULL

*	NULL
This	NULL
work	NULL
was	NULL
supported	NULL
in	NULL
part	NULL
by	NULL
the	NULL
Associazione	NULL
Italiana	NULL
per	NULL
la	NULL
Ricerca	NULL
sul	NULL
Cancro	NULL
(	NULL
to	NULL
M.	NULL
M.	NULL
and	NULL
C.	NULL
P.	NULL
)	NULL
,	NULL
by	NULL
the	NULL
Progetto	NULL
Ricerca	NULL
Finaliz-zata	NULL
1993	NULL
and	NULL
1995	NULL
(	NULL
to	NULL
M.	NULL
M.	NULL
)	NULL
,	NULL
and	NULL
by	NULL
the	NULL
Ministero	NULL
dell'Universita	NULL
e	NULL
Ricerca	NULL
Scientifica	NULL
e	NULL
Tecnologica	NULL
(	NULL
to	NULL
C.	NULL
P.	NULL
)	NULL
.	NULL

2	NULL
To	NULL
whom	NULL
requests	NULL
for	NULL
reprints	NULL
should	NULL
be	NULL
addressed	NULL
.	NULL

Phone	NULL
:	NULL
39-434-659342	NULL
;	NULL
Fax	NULL
:	NULL
39-434-659566	NULL
.	NULL

Introduction	NULL
It	NULL
has	NULL
recently	NULL
been	NULL
demonstrated	NULL
that	NULL
stimulation	NULL
of	NULL
B	NULL
cells	NULL
via	NULL
HLA	NULL
or	NULL
MHC	NULL
class	NULL
II	NULL
antigens	NULL
transduces	NULL
intracellular	NULL
signals	NULL
mediating	NULL
different	NULL
biological	NULL
phenomena	NULL
,	NULL
including	NULL
homotypic	NULL
cell	NULL
aggregation	NULL
(	NULL
1-3	NULL
)	NULL
,	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
(	NULL
4	NULL
)	NULL
,	NULL
immunoglobulin	NULL
secretion	NULL
(	NULL
5	NULL
)	NULL
,	NULL
cell	NULL
surface	NULL
induction	NULL
of	NULL
the	NULL
costimulatory	NULL
molecule	NULL
B7	NULL
(	NULL
6	NULL
,	NULL
7	NULL
)	NULL
,	NULL
and	NULL
TNF-a°	NULL
release	NULL
by	NULL
EBV+B	NULL
cells	NULL
JY	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
local	NULL
release	NULL
of	NULL
selected	NULL
cytokines	NULL
and	NULL
cell-cell	NULL
inter-action	NULL
(	NULL
s	NULL
)	NULL
are	NULL
central	NULL
points	NULL
in	NULL
B-cell	NULL
development	NULL
(	NULL
9	NULL
)	NULL
,	NULL
differentiation	NULL
(	NULL
10	NULL
)	NULL
,	NULL
and	NULL
activation	NULL
(	NULL
11	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
growth	NULL
factors	NULL
and	NULL
cytokines	NULL
may	NULL
exert	NULL
an	NULL
autocrine	NULL
function	NULL
by	NULL
binding	NULL
to	NULL
specific	NULL
cell	NULL
surface	NULL
receptors	NULL
.	NULL

Receptor	NULL
occupancy	NULL
triggers	NULL
a	NULL
tightly	NULL
coordinated	NULL
multistep	NULL
signal	NULL
transduction	NULL
cascade	NULL
to	NULL
the	NULL
nucleus	NULL
(	NULL
12	NULL
)	NULL
.	NULL

In	NULL
this	NULL
cascade	NULL
,	NULL
nuclear	NULL
transcription	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
serve	NULL
as	NULL
terminal	NULL
acceptors	NULL
responsible	NULL
for	NULL
executing	NULL
long-term	NULL
responses	NULL
modulating	NULL
gene	NULL
expression	NULL
and	NULL
TNF-a	NULL
release	NULL
(	NULL
13	NULL
,	NULL
14	NULL
)	NULL
.	NULL

The	NULL
aims	NULL
of	NULL
this	NULL
study	NULL
were	NULL
to	NULL
investigate	NULL
the	NULL
role	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
B	NULL
cells	NULL
at	NULL
different	NULL
stage	NULL
of	NULL
maturation	NULL
and	NULL
to	NULL
evaluate	NULL
its	NULL
autocrine	NULL
effects	NULL
on	NULL
nuclear	NULL
binding	NULL
activity	NULL
,	NULL
homotypic	NULL
cell	NULL
aggregation	NULL
,	NULL
and	NULL
cell	NULL
proliferation	NULL
.	NULL

The	NULL
experimental	NULL
data	NULL
we	NULL
obtained	NULL
demonstrate	NULL
that	NULL
the	NULL
engagement	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
selected	NULL
mAbs	NULL
transduces	NULL
an	NULL
intracellular	NULL
signal	NULL
(	NULL
s	NULL
)	NULL
that	NULL
up-regulates	NULL
the	NULL
levels	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
and	NULL
its	NULL
release	NULL
by	NULL
B	NULL
cells	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
and	NULL
Sc-1	NULL
,	NULL
which	NULL
are	NULL
at	NULL
a	NULL
distinct	NULL
stage	NULL
of	NULL
differentiation	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
by	NULL
the	NULL
more	NULL
differentiated	NULL
B	NULL
cell	NULL
Raji	NULL
(	NULL
16	NULL
)	NULL
but	NULL
not	NULL
by	NULL
the	NULL
pre-B	NULL
cells	NULL
Nalm-6	NULL
(	NULL
17	NULL
)	NULL
and	NULL
BV173	NULL
(	NULL
18	NULL
)	NULL
.	NULL

The	NULL
intracellular	NULL
signal	NULL
(	NULL
s	NULL
)	NULL
mediating	NULL
TNF-a	NULL
release	NULL
is	NULL
independent	NULL
from	NULL
those	NULL
signals	NULL
leading	NULL
to	NULL
homotypic	NULL
cell	NULL
aggregation	NULL
and	NULL
inhibition	NULL
of	NULL
cell	NULL
proliferation	NULL
.	NULL

Lastly	NULL
,	NULL
our	NULL
data	NULL
show	NULL
that	NULL
secreted	NULL
TNF-a	NULL
up-regulates	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
activity	NULL
in	NULL
B	NULL
cells	NULL
at	NULL
different	NULL
stage	NULL
of	NULL
maturation	NULL
.	NULL

Results	NULL
Modulation	NULL
of	NULL
TNF-	NULL
«	NULL
Release	NULL
after	NULL
the	NULL
Triggering	NULL
of	NULL
HLA-DR	NULL
,	NULL
Antigens	NULL
.	NULL

To	NULL
investigate	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
expressed	NULL
on	NULL
B	NULL
cells	NULL
at	NULL
a	NULL
distinct	NULL
stage	NULL
of	NULL
maturation	NULL
,	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
Ri-l	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-1	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
were	NULL
grown	NULL
for	NULL
24	NULL
h	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
g/m	NULL
!	NULL

anti-HLA-DR	NULL
mAb	NULL
L243	NULL
or	NULL
10	NULL
ug/ml	NULL
mAb	NULL
2.06	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
L243	NULL
induced	NULL
or	NULL
enhanced	NULL
the	NULL
accumulation	NULL
of	NULL
TNF-a	NULL
in	NULL
the	NULL
culture	NULL
super	NULL
®	NULL
The	NULL
abbreviations	NULL
used	NULL
are	NULL
:	NULL
TNF-a	NULL
,	NULL
tumor	NULL
necrosis	NULL
factor	NULL
a	NULL
;	NULL
EBV+B	NULL
,	NULL
EBV-transformed	NULL
B	NULL
lymphoblastoid	NULL
;	NULL
NF-	NULL
«	NULL
B	NULL
,	NULL
nuclear	NULL
factor	NULL
«	NULL
B	NULL
;	NULL
AP-1	NULL
,	NULL
activator	NULL
protein-	NULL
1	NULL
;	NULL
mAb	NULL
,	NULL
moneclonal	NULL
antibody	NULL
;	NULL
PMA	NULL
,	NULL
phorbol	NULL
12-myristate	NULL
13-acetate	NULL
;	NULL
EMSA	NULL
,	NULL
electrophoretic	NULL
mobility	NULL
shift	NULL
assay	NULL
;	NULL
TSST-1	NULL
,	NULL
toxin	NULL
shock	NULL
syndrome	NULL
toxin-1	NULL
.	NULL

HLA-DR	NULL
Antigen-mediated	NULL
TNF-a	NULL
Release	NULL
in	NULL
B	NULL
Cells	NULL
200	NULL
100	NULL
TNF-	NULL
a	NULL
(	NULL
pg/ml	NULL
)	NULL
Nalm6	NULL
BV173	NULL
-	NULL
RHI	NULL
__	NULL
Cit	NULL
__	NULL
Se-l	NULL
__	NULL
Raji	NULL
Cells	NULL
Fig	NULL
.	NULL

1.	NULL
.	NULL

Modulation	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
B-cell	NULL
lines	NULL
at	NULL
a	NULL
distinct	NULL
stage	NULL
of	NULL
maturation	NULL
after	NULL
the	NULL
cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

Cultures	NULL
of	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
10	NULL
g/ml	NULL
mAb	NULL
L243	NULL
(	NULL
C	NULL
)	NULL
or	NULL
10	NULL
ug/ml	NULL
mAb	NULL
2.06	NULL
(	NULL
§	NULL
)	NULL
,	NULL
plated	NULL
in	NULL
24-well	NULL
flat-bottomed	NULL
plates	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
cultures	NULL
(	NULL
@	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
mAb	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
a	NULL
24-h	NULL
incubation	NULL
,	NULL
cultures	NULL
were	NULL
harvested	NULL
and	NULL
spun	NULL
at	NULL
400	NULL
x	NULL
g	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
frozen	NULL
at	NULL
-80°C	NULL
.	NULL

Then	NULL
,	NULL
supernatants	NULL
were	NULL
tested	NULL
in	NULL
triplicate	NULL
for	NULL
their	NULL
content	NULL
of	NULL
TNF-a	NULL
in	NULL
the	NULL
ELISA	NULL
assay	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
versus	NULL
control	NULL
.	NULL

1200	NULL
|-	NULL
a	NULL
3a	NULL
€	NULL
3	NULL
-	NULL
800	NULL
a.	NULL
Nat	NULL
#	NULL
U	NULL
Us	NULL
-	NULL
400	NULL
i-0	NULL
Nalm-6	NULL
BV173	NULL
_	NULL
Ri-l	NULL
Ciel	NULL
Se-l	NULL
__	NULL
Raji	NULL
Cells	NULL
Fig	NULL
.	NULL

2	NULL
.	NULL

-	NULL
Modulation	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
B-cell	NULL
lines	NULL
at	NULL
a	NULL
distinct	NULL
stage	NULL
of	NULL
maturation	NULL
after	NULL
stimulation	NULL
with	NULL
PMA	NULL
.	NULL

Cultures	NULL
of	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
10	NULL
ng/ml	NULL
PMA	NULL
(	NULL
C	NULL
)	NULL
)	NULL
,	NULL
plated	NULL
in	NULL
24-well	NULL
flat-bottomed	NULL
plates	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
cultures	NULL
@	NULL
@	NULL
)	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
PMA	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
a	NULL
24-h	NULL
incubation	NULL
,	NULL
cultures	NULL
were	NULL
harvested	NULL
and	NULL
spun	NULL
at	NULL
400	NULL
x	NULL
g	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
frozen	NULL
at	NULL
-80°C	NULL
.	NULL

Then	NULL
supernatants	NULL
were	NULL
tested	NULL
in	NULL
triplicate	NULL
for	NULL
their	NULL
content	NULL
of	NULL
TNF-a	NULL
in	NULL
the	NULL
ELISA	NULL
assay	NULL
.	NULL

Data	NULL
represent	NULL
the	NULL
mean	NULL
values	NULL
+	NULL
SD	NULL
of	NULL
four	NULL
experiments	NULL
.	NULL

*	NULL
,	NULL
P	NULL
<	NULL
0.05	NULL
versus	NULL
control	NULL
.	NULL

natant	NULL
of	NULL
Ri-l	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
as	NULL
compared	NULL
to	NULL
control	NULL
cultures	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
induction	NULL
of	NULL
TNF-a	NULL
release	NULL
was	NULL
observed	NULL
for	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

Fig	NULL
.	NULL

1	NULL
shows	NULL
the	NULL
amount	NULL
of	NULL
TNF-a	NULL
released	NULL
in	NULL
the	NULL
supernatant	NULL
of	NULL
cultured	NULL
B	NULL
cells	NULL
under	NULL
study	NULL
in	NULL
four	NULL
independent	NULL
experiments	NULL
.	NULL

Results	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
whole	NULL
immunoglobulin	NULL
molecule	NULL
of	NULL
mAb	NULL
L243	NULL
were	NULL
observed	NULL
by	NULL
using	NULL
its	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
release	NULL
of	NULL
TNF-	NULL
«	NULL
was	NULL
not	NULL
affected	NULL
by	NULL
incubating	NULL
B	NULL
cells	NULL
under	NULL
similar	NULL
experimental	NULL
conditions	NULL
using	NULL
the	NULL
anti-HLA-DR	NULL
mAb	NULL
2.06	NULL
(	NULL
Fig	NULL
.	NULL

1	NULL
)	NULL
.	NULL

All	NULL
B	NULL
cells	NULL
investigated	NULL
released	NULL
TNF-a	NULL
after	NULL
treatment	NULL
with	NULL
10	NULL
ng/m	NULL
!	NULL

PMA	NULL
for	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

2	NULL
)	NULL
.	NULL

150	NULL
F	NULL
100	NULL
F	NULL
S0	NULL
F	NULL
TNF-	NULL
a	NULL
(	NULL
pg/ml	NULL
)	NULL
Time	NULL
(	NULL
hrs	NULL
)	NULL
Fig	NULL
.	NULL

3	NULL
.	NULL

-	NULL
Time-dependent	NULL
modulation	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
Nalm-6	NULL
and	NULL
Raji	NULL
cells	NULL
after	NULL
cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

Cultures	NULL
of	NULL
Nalm-6	NULL
(	NULL
-	NULL
-	NULL
-	NULL
-	NULL
-	NULL
)	NULL
and	NULL
Raji	NULL
(	NULL
--	NULL
)	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/m	NULL
!	NULL
)	NULL

were	NULL
supplemented	NULL
with	NULL
anti-HLA-DR	NULL
mAb	NULL
L243	NULL
(	NULL
@	NULL
)	NULL
or	NULL
mAb	NULL
2.06	NULL
(	NULL
0	NULL
)	NULL
,	NULL
both	NULL
used	NULL
at	NULL
10	NULL
ug/ml	NULL
,	NULL
plated	NULL
in	NULL
24-well	NULL
flat-bottomed	NULL
plates	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
cultures	NULL
of	NULL
Nalm-6	NULL
cells	NULL
(	NULL
A	NULL
)	NULL
or	NULL
Raji	NULL
cells	NULL
(	NULL
&	NULL
)	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
mAb	NULL
.	NULL

At	NULL
the	NULL
indicated	NULL
times	NULL
,	NULL
cultures	NULL
were	NULL
harvested	NULL
and	NULL
spun	NULL
at	NULL
400	NULL
x	NULL
g	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
frozen	NULL
at	NULL
-80°C	NULL
.	NULL

Then	NULL
supernatants	NULL
were	NULL
tested	NULL
in	NULL
triplicate	NULL
for	NULL
their	NULL
content	NULL
of	NULL
TNF-a	NULL
in	NULL
the	NULL
ELISA	NULL
assay	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

Time-	NULL
and	NULL
Dose-dependent	NULL
TNF-a	NULL
Release	NULL
by	NULL
Naim-6	NULL
and	NULL
Raji	NULL
Cells	NULL
after	NULL
the	NULL
Triggering	NULL
of	NULL
HLA-DR	NULL
Antigens	NULL
.	NULL

The	NULL
up-regulation	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
Ri-l	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
L243	NULL
was	NULL
found	NULL
to	NULL
be	NULL
time	NULL
and	NULL
dose	NULL
dependent	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
for	NULL
different	NULL
times	NULL
and	NULL
with	NULL
different	NULL
concentrations	NULL
of	NULL
mAb	NULL
L243	NULL
did	NULL
not	NULL
induce	NULL
TNF-a	NULL
release	NULL
by	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
cells	NULL
.	NULL

Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
show	NULL
the	NULL
time	NULL
and	NULL
dose	NULL
dependency	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
Raji	NULL
and	NULL
Nalm-6	NULL
cells	NULL
,	NULL
representative	NULL
of	NULL
three	NULL
independent	NULL
experiments	NULL
.	NULL

A	NULL
2-3-fold	NULL
increase	NULL
in	NULL
the	NULL
amount	NULL
of	NULL
TNF-a	NULL
detectable	NULL
in	NULL
the	NULL
culture	NULL
supernatant	NULL
of	NULL
Raji	NULL
cells	NULL
was	NULL
observed	NULL
after	NULL
6	NULL
h	NULL
of	NULL
treatment	NULL
with	NULL
10	NULL
g/ml	NULL
of	NULL
mAb	NULL
1243	NULL
;	NULL
cytokine	NULL
accumulation	NULL
peaked	NULL
at	NULL
24	NULL
h	NULL
and	NULL
decreased	NULL
thereafter	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
.	NULL

The	NULL
up-regulation	NULL
of	NULL
TNF-a	NULL
release	NULL
reached	NULL
its	NULL
maximum	NULL
when	NULL
mAb	NULL
L243	NULL
at	NULL
10	NULL
ug/ml	NULL
was	NULL
used	NULL
,	NULL
and	NULL
it	NULL
was	NULL
still	NULL
marked	NULL
when	NULL
1	NULL
ug/ml	NULL
mAb	NULL
was	NULL
used	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
;	NULL
in	NULL
contrast	NULL
,	NULL
the	NULL
amounts	NULL
of	NULL
TNF-a	NULL
detectable	NULL
after	NULL
triggering	NULL
with	NULL
0.1	NULL
ug/ml	NULL
of	NULL
mAb	NULL
L243	NULL
were	NULL
similar	NULL
to	NULL
control	NULL
values	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
.	NULL

Nalm-6	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
BV173	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
cultured	NULL
under	NULL
similar	NULL
experimental	NULL
conditions	NULL
did	NULL
not	NULL
release	NULL
detectable	NULL
amounts	NULL
of	NULL
TNF-a	NULL
.	NULL

Results	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
Raji	NULL
cells	NULL
were	NULL
obtained	NULL
with	NULL
Ri-l	NULL
,	NULL
Ci-l	NULL
,	NULL
and	NULL
Sc-l	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
for	NULL
different	NULL
times	NULL
(	NULL
Fig	NULL
.	NULL

3	NULL
)	NULL
and	NULL
with	NULL
different	NULL
concentrations	NULL
(	NULL
Fig	NULL
.	NULL

4	NULL
)	NULL
of	NULL
mAb	NULL
2.06	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
by	NULL
Raji	NULL
and	NULL
Nalm-6	NULL
cells	NULL
(	NULL
Figs	NULL
.	NULL

3	NULL
and	NULL
4	NULL
)	NULL
and	NULL
by	NULL
BV173	NULL
,	NULL
Ri-l	NULL
,	NULL
Ci-l	NULL
,	NULL
and	NULL
Sc-l	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Expression	NULL
of	NULL
HLA-DR	NULL
Antigens	NULL
on	NULL
B	NULL
Cells	NULL
under	NULL
Study	NULL
.	NULL

The	NULL
expression	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
investigated	NULL
B	NULL
cells	NULL
was	NULL
studied	NULL
by	NULL
indirect	NULL
immunofluorescence	NULL
using	NULL
mAb	NULL
L243	NULL
and	NULL
mAb	NULL
2.06	NULL
.	NULL

The	NULL
values	NULL
of	NULL
mean	NULL
fluorescence	NULL
intensity	NULL
,	NULL
which	NULL
are	NULL
an	NULL
indirect	NULL
expression	NULL
of	NULL
antigen	NULL
density	NULL
,	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
300	NULL
f	NULL
200	NULL
|	NULL
100	NULL
¢	NULL
TNF-	NULL
a	NULL
(	NULL
pg/ml	NULL
)	NULL
mAb	NULL
(	NULL
ug/ml	NULL
)	NULL
Fig	NULL
.	NULL

4	NULL
.	NULL

Dose-dependent	NULL
modulation	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
Nalm-6	NULL
and	NULL
Raji	NULL
cells	NULL
after	NULL
cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

Cultures	NULL
of	NULL
Nalim-6	NULL
(	NULL
+-~~~	NULL
)	NULL
and	NULL
Raji	NULL
(	NULL
--	NULL
)	NULL
cells	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/ml	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
the	NULL
indicated	NULL
amounts	NULL
of	NULL
anti-HLA-DR	NULL
mAb	NULL
L243	NULL
(	NULL
@	NULL
)	NULL
or	NULL
mAb	NULL
2.06	NULL
(	NULL
0	NULL
)	NULL
,	NULL
plated	NULL
in	NULL
24-well	NULL
flat-bottomed	NULL
plates	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
cultures	NULL
of	NULL
Nalm-6	NULL
cells	NULL
{	NULL
A	NULL
)	NULL
or	NULL
Raji	NULL
cells	NULL
(	NULL
&	NULL
)	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
mAb	NULL
.	NULL

After	NULL
a	NULL
24-h	NULL
incubation	NULL
,	NULL
cultures	NULL
were	NULL
harvested	NULL
and	NULL
spun	NULL
at	NULL
400	NULL
x	NULL
g	NULL
,	NULL
and	NULL
supernatants	NULL
were	NULL
frozen	NULL
at	NULL
-80°C	NULL
.	NULL

Then	NULL
supernatants	NULL
were	NULL
tested	NULL
in	NULL
triplicates	NULL
for	NULL
their	NULL
content	NULL
of	NULL
TNF-a	NULL
in	NULL
the	NULL
ELISA	NULL
assay	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

were	NULL
148	NULL
,	NULL
102	NULL
,	NULL
51	NULL
,	NULL
49	NULL
,	NULL
91	NULL
,	NULL
and	NULL
94	NULL
with	NULL
mAb	NULL
L243	NULL
and	NULL
137	NULL
,	NULL
95	NULL
,	NULL
54	NULL
,	NULL
50	NULL
,	NULL
87	NULL
,	NULL
and	NULL
96	NULL
with	NULL
mAb	NULL
2.06	NULL
for	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
,	NULL
respectively	NULL
.	NULL

Modulation	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
Levels	NULL
after	NULL
the	NULL
Triggering	NULL
of	NULL
HLA-DR	NULL
Antigens	NULL
on	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
and	NULL
Raji	NULL
Cells	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
L243	NULL
or	NULL
mAb	NULL
2.06	NULL
on	NULL
TNF-	NULL
«	NULL
mRNA	NULL
level	NULL
was	NULL
investigated	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
.	NULL

Fig	NULL
.	NULL

5	NULL
shows	NULL
the	NULL
increase	NULL
in	NULL
TNF-	NULL
«	NULL
mRNA	NULL
in	NULL
Raji	NULL
cells	NULL
detected	NULL
after	NULL
3	NULL
h	NULL
of	NULL
culture	NULL
with	NULL
10	NULL
ug/ml	NULL
mAb	NULL
L243	NULL
but	NULL
not	NULL
with	NULL
mAb	NULL
2.06	NULL
.	NULL

No	NULL
induction	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
was	NULL
observed	NULL
after	NULL
treatment	NULL
of	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
cells	NULL
with	NULL
either	NULL
mAb	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

However	NULL
,	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
increased	NULL
in	NULL
the	NULL
three	NULL
cell	NULL
lines	NULL
under	NULL
study	NULL
after	NULL
3	NULL
h	NULL
of	NULL
treatment	NULL
with	NULL
10	NULL
ng/ml	NULL
PMA	NULL
(	NULL
Fig	NULL
.	NULL

5	NULL
)	NULL
.	NULL

The	NULL
increase	NULL
in	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
of	NULL
Raji	NULL
cells	NULL
treated	NULL
with	NULL
mAb	NULL
L243	NULL
or	NULL
PMA	NULL
was	NULL
time	NULL
dependent	NULL
.	NULL

It	NULL
peaked	NULL
at	NULL
3	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
decreased	NULL
thereafter	NULL
,	NULL
and	NULL
returned	NULL
to	NULL
baseline	NULL
levels	NULL
at	NULL
24	NULL
h	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

No	NULL
change	NULL
in	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
was	NULL
observed	NULL
when	NULL
BV173	NULL
cells	NULL
were	NULL
treated	NULL
with	NULL
mAb	NULL
L243	NULL
under	NULL
similar	NULL
experimental	NULL
conditions	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
treatment	NULL
of	NULL
BV173	NULL
cells	NULL
with	NULL
PMA	NULL
increased	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
with	NULL
a	NULL
kinetic	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
Raji	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

6	NULL
)	NULL
.	NULL

Enhancement	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
Binding	NULL
Activity	NULL
after	NULL
the	NULL
Triggering	NULL
of	NULL
HLA-DR	NULL
Antigens	NULL
.	NULL

To	NULL
investigate	NULL
whether	NULL
cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
would	NULL
be	NULL
able	NULL
to	NULL
regulate	NULL
the	NULL
transcriptional	NULL
machinery	NULL
and	NULL
whether	NULL
released	NULL
TNF-a	NULL
might	NULL
have	NULL
a	NULL
role	NULL
in	NULL
such	NULL
phenomena	NULL
,	NULL
we	NULL
investigated	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
binding	NULL
activity	NULL
in	NULL
the	NULL
cell	NULL
lines	NULL
under	NULL
study	NULL
.	NULL

Nuclear	NULL
extracts	NULL
of	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
Ri-l	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
,	NULL
incubated	NULL
with	NULL
or	NULL
without	NULL
mAb	NULL
L243	NULL
,	NULL
were	NULL
analyzed	NULL
by	NULL
EMSA	NULL
.	NULL

Treatment	NULL
with	NULL
10	NULL
ug/ml	NULL
of	NULL
mAb	NULL
L243	NULL
for	NULL
1	NULL
h	NULL
up-regulated	NULL
NF-kB	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
binding	NULL
activity	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
but	NULL
not	NULL
in	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
cells	NULL
.	NULL

The	NULL
specificity	NULL
of	NULL
the	NULL
up-regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
binding	NULL
activity	NULL
was	NULL
confirmed	NULL
by	NULL
competition	NULL
with	NULL
a	NULL
molar	NULL
excess	NULL
of	NULL
unlabeled	NULL
probes	NULL
for	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
Fig	NULL
.	NULL

7A	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
Fig	NULL
.	NULL

7B	NULL
)	NULL
or	NULL
the	NULL
unrelated	NULL
oligonucleotide	NULL
Sp1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
did	NULL
not	NULL
influence	NULL
Spt	NULL
binding	NULL
activity	NULL
in	NULL
all	NULL
cell	NULL
lines	NULL
under	NULL
study	NULL
(	NULL
Fig	NULL
.	NULL

7C	NULL
)	NULL
.	NULL

Polyclonal	NULL
anti-TNF-a	NULL
«	NULL
neutralizing	NULL
antibody	NULL
inhibited	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
enhanced	NULL
by	NULL
mAb	NULL
L243	NULL
in	NULL
Raji	NULL
cells	NULL
but	NULL
did	NULL
not	NULL
affect	NULL
NF-	NULL
«	NULL
B	NULL
binding	NULL
activity	NULL
in	NULL
Nalm-6	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

8	NULL
)	NULL
.	NULL

Similar	NULL
results	NULL
were	NULL
obtained	NULL
with	NULL
Raji	NULL
and	NULL
Nalm-6	NULL
cells	NULL
for	NULL
AP-1	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Modulation	NULL
of	NULL
Cell	NULL
Proliferation	NULL
and	NULL
Homotypic	NULL
Cell	NULL
Aggregation	NULL
after	NULL
the	NULL
Triggering	NULL
of	NULL
HLA-DR	NULL
Antigens	NULL
.	NULL

The	NULL
effect	NULL
of	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
L243	NULL
or	NULL
mAb	NULL
2.06	NULL
on	NULL
the	NULL
proliferation	NULL
of	NULL
Nalm-6	NULL
,	NULL
Ri-1	NULL
,	NULL
Ci-l	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
was	NULL
investigated	NULL
by	NULL
[	NULL
°HIthymidine	NULL
uptake	NULL
.	NULL

Data	NULL
from	NULL
three	NULL
independent	NULL
experiments	NULL
in	NULL
which	NULL
cells	NULL
were	NULL
cultured	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
either	NULL
mAb	NULL
for	NULL
24	NULL
h	NULL
are	NULL
reported	NULL
in	NULL
Table	NULL
1	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
did	NULL
not	NULL
affect	NULL
[	NULL
}	NULL
HJthymidine	NULL
uptake	NULL
by	NULL
the	NULL
B	NULL
cells	NULL
investigated	NULL
to	NULL
a	NULL
statistically	NULL
significant	NULL
extent	NULL
.	NULL

incorporation	NULL
by	NULL
Nalm-6	NULL
,	NULL
Ri-1	NULL
,	NULL
Ci-I	NULL
,	NULL
Sc-I	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
was	NULL
not	NULL
influenced	NULL
even	NULL
by	NULL
prolonging	NULL
their	NULL
incubation	NULL
with	NULL
mAb	NULL
L243	NULL
or	NULL
mAb	NULL
2.06	NULL
for	NULL
up	NULL
to	NULL
72	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
with	NULL
10	NULL
ug/ml	NULL
mAb	NULL
L243	NULL
induced	NULL
homotypic	NULL
aggregation	NULL
of	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
.	NULL

The	NULL
effect	NULL
was	NULL
time	NULL
dependent	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
,	NULL
and	NULL
cell	NULL
aggregates	NULL
included	NULL
>	NULL
50	NULL
%	NULL
of	NULL
cells	NULL
after	NULL
1	NULL
h	NULL
of	NULL
culture	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
.	NULL

In	NULL
contrast	NULL
,	NULL
no	NULL
aggregation	NULL
of	NULL
Nalm-6	NULL
(	NULL
Ta-bie	NULL
1	NULL
)	NULL
and	NULL
BV173	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
was	NULL
observed	NULL
after	NULL
1	NULL
h	NULL
of	NULL
culture	NULL
with	NULL
mAb	NULL
L243	NULL
or	NULL
when	NULL
incubation	NULL
with	NULL
the	NULL
mAb	NULL
was	NULL
prolonged	NULL
up	NULL
to	NULL
6	NULL
h	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
2.06	NULL
had	NULL
no	NULL
effect	NULL
on	NULL
homotypic	NULL
aggregation	NULL
of	NULL
Nalm-6	NULL
,	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-1	NULL
,	NULL
Raji	NULL
(	NULL
Table	NULL
1	NULL
)	NULL
,	NULL
and	NULL
BV173	NULL
cells	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

The	NULL
addition	NULL
of	NULL
polyclonal	NULL
anti-TNF-	NULL
«	NULL
neutralizing	NULL
antibody	NULL
did	NULL
not	NULL
affect	NULL
homotypic	NULL
aggregation	NULL
of	NULL
B	NULL
cells	NULL
induced	NULL
by	NULL
mAb	NULL
L243	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Results	NULL
similar	NULL
to	NULL
those	NULL
obtained	NULL
with	NULL
the	NULL
whole	NULL
immunoglobulin	NULL
molecule	NULL
were	NULL
observed	NULL
by	NULL
using	NULL
F	NULL
(	NULL
ab	NULL
'	NULL
)	NULL
,	NULL
fragments	NULL
of	NULL
mAb	NULL
L243	NULL
under	NULL
similar	NULL
experimental	NULL
conditions	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Discussion	NULL
In	NULL
addition	NULL
to	NULL
their	NULL
classical	NULL
role	NULL
as	NULL
antigen-presenting	NULL
molecules	NULL
to	NULL
T	NULL
cells	NULL
(	NULL
19	NULL
)	NULL
,	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
expressed	NULL
on	NULL
different	NULL
cell	NULL
types	NULL
can	NULL
act	NULL
as	NULL
signal-transducing	NULL
structures	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
on	NULL
B	NULL
cells	NULL
activates	NULL
phosphatidyl	NULL
inositol	NULL
turnover	NULL
increasing	NULL
intracellular	NULL
Ca**	NULL
concentration	NULL
(	NULL
20	NULL
,	NULL
21	NULL
)	NULL
and	NULL
induces	NULL
protein	NULL
tyrosine	NULL
phosphorylation	NULL
(	NULL
20	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
by	NULL
staphylococcal	NULL
superantigens	NULL
activates	NULL
tyrosine	NULL
phosphorylation	NULL
and	NULL
translocation	NULL
of	NULL
protein	NULL
kinase	NULL
C	NULL
in	NULL
monocytic	NULL
cells	NULL
(	NULL
22	NULL
)	NULL
and	NULL
activates	NULL
interleukin	NULL
6	NULL
and	NULL
interleukin	NULL
8	NULL
gene	NULL
expression	NULL
in	NULL
IFN-y-treated	NULL
human	NULL
rheu-matoid	NULL
fibroblast-like	NULL
synoviocytes	NULL
(	NULL
23	NULL
)	NULL
.	NULL

HLA	NULL
class	NULL
II	NULL
antigens	NULL
are	NULL
highly	NULL
expressed	NULL
throughout	NULL
B-cell	NULL
development	NULL
(	NULL
24	NULL
)	NULL
and	NULL
differentiation	NULL
(	NULL
25	NULL
)	NULL
;	NULL
nevertheless	NULL
,	NULL
their	NULL
functional	NULL
role	NULL
in	NULL
discrete	NULL
steps	NULL
of	NULL
B-cell	NULL
matura-	NULL
HLA-DR	NULL
Antigen-mediated	NULL
TNF-a	NULL
Release	NULL
in	NULL
B	NULL
Celis	NULL
Fig	NULL
.	NULL

5	NULL
.	NULL

Analysis	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
after	NULL
&	NULL
&	NULL
x	NULL
]	NULL
g	NULL
g	NULL
a	NULL
g	NULL
a	NULL
g	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
€	NULL
u	NULL
a	NULL
€	NULL
u	NULL
a	NULL
€	NULL
a	NULL
-	NULL
a	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
and	NULL
Raiji	NULL
cells	NULL
.	NULL

Cultures	NULL
of	NULL
3	NULL
a	NULL
a	NULL
3	NULL
a	NULL
a	NULL
3	NULL
a	NULL
a	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
8	NULL
<	NULL
<	NULL
g	NULL
5	NULL
<	NULL
<	NULL
E	NULL
E	NULL
<	NULL
4	NULL
4	NULL
é	NULL
cells/m	NULL
!	NULL
)	NULL

were	NULL
supplemented	NULL
with	NULL
mAb	NULL
=	NULL
E	NULL
E	NULL
#	NULL
E	NULL
E	NULL
E	NULL
_E	NULL
L243	NULL
or	NULL
mAb	NULL
2.06	NULL
,	NULL
both	NULL
used	NULL
at	NULL
10	NULL
ug/ml	NULL
,	NULL
or	NULL
with	NULL
10	NULL
ng/m	NULL
!	NULL

PMA	NULL
,	NULL
plated	NULL
in	NULL
T25	NULL
flasks	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
.	NULL

Control	NULL
TNF-	NULL
«	NULL
«	NULL
uite	NULL
.	NULL

e	NULL
``	NULL
``	NULL
cultures	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
stimuli	NULL
.	NULL

At	NULL
the	NULL
end	NULL
of	NULL
a	NULL
3-h	NULL
incubation	NULL
,	NULL
cultures	NULL
were	NULL
harvested	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
ex-fen	NULL
tracted	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
loaded	NULL
B.actin	NULL
.	NULL

.	NULL

-	NULL
u	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose-EE	NULL
Fa	NULL
``	NULL
a	NULL
|	NULL
|	NULL
formaldehyde	NULL
gel	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
ny-Ion32	NULL
membrane	NULL
,	NULL
-	NULL
and	NULL
-	NULL
hybridized	NULL
|	NULL
with	NULL
a	NULL
[	NULL
a-*°P	NULL
]	NULL
dCTP-radiolabeled	NULL
cDNA	NULL
probes	NULL
Nalm-6	NULL
BV173	NULL
Raji	NULL
for	NULL
TNF-a	NULL
and	NULL
B-actin	NULL
.	NULL

mAb	NULL
L243	NULL
PMA	NULL
Oh	NULL
3h	NULL
6h	NULL
12h	NULL
24h	NULL
3h	NULL
6h	NULL
12h	NULL
24h	NULL
Fig	NULL
.	NULL

6	NULL
.	NULL

Time-dependent	NULL
-	NULL
modulation	NULL
-	NULL
of	NULL
.	NULL

TNF-a	NULL
mRNA	NULL
level	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
TNF-	NULL
(	NULL
L	NULL
«	NULL
ip	NULL
.	NULL

le	NULL
cal	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
BV173	NULL
and	NULL
Raji	NULL
cels	NULL
.	NULL

aa	NULL
Cultures	NULL
of	NULL
BV173	NULL
and	NULL
Raji	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
Raji	NULL
cells/mi	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
10	NULL
ug/ml	NULL
mAb	NULL
L243	NULL
or	NULL
with	NULL
10	NULL
ng/ml	NULL
PMA	NULL
,	NULL
plated	NULL
in	NULL
&	NULL
T25	NULL
flasks	NULL
,	NULL
and	NULL
incubated	NULL
at	NULL
37°C	NULL
for	NULL
the	NULL
B-actin	NULL
P	NULL
@	NULL
UR	NULL
OD	NULL
wa	NULL
.	NULL

“	NULL
indicated	NULL
times	NULL
.	NULL

Then	NULL
,	NULL
cultures	NULL
were	NULL
harvested	NULL
and	NULL
total	NULL
RNA	NULL
was	NULL
extracted	NULL
.	NULL

Ten	NULL
ug	NULL
of	NULL
total	NULL
RNA	NULL
were	NULL
loaded	NULL
in	NULL
each	NULL
lane	NULL
,	NULL
separated	NULL
on	NULL
a	NULL
1	NULL
%	NULL
agarose-formaldeyde	NULL
gel	NULL
,	NULL
transferred	NULL
onto	NULL
a	NULL
nylon	NULL
membrane	NULL
,	NULL
and	NULL
hy-	NULL
ak	NULL
--	NULL
--	NULL
]	NULL
bridized	NULL
_	NULL
with	NULL
_	NULL
[	NULL
a-°2P	NULL
]	NULL
dCTP-radiolabeled	NULL
cDNA	NULL
probes	NULL
for	NULL
TNF-a	NULL
and	NULL
B-actin	NULL
.	NULL

Filters	NULL
we	NULL
were	NULL
then	NULL
processed	NULL
for	NULL
autoradiography	NULL
.	NULL

TNF	NULL
'	NULL
U	NULL
BV173	NULL
&	NULL
‘	NULL
tion	NULL
is	NULL
not	NULL
fully	NULL
understood	NULL
.	NULL

In	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
up-regulates	NULL
the	NULL
constitutive	NULL
release	NULL
of	NULL
TNF-a	NULL
(	NULL
8	NULL
)	NULL
,	NULL
induces	NULL
homotypic	NULL
cell	NULL
aggregation	NULL
(	NULL
1	NULL
,	NULL
8	NULL
)	NULL
,	NULL
inhibits	NULL
cell	NULL
proliferation	NULL
(	NULL
4	NULL
,	NULL
5	NULL
,	NULL
8	NULL
)	NULL
,	NULL
and	NULL
enhances	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Cytokine	NULL
release	NULL
and	NULL
cellular	NULL
interactions	NULL
are	NULL
important	NULL
events	NULL
in	NULL
B-cell	NULL
maturation	NULL
(	NULL
9-11	NULL
)	NULL
,	NULL
and	NULL
to	NULL
the	NULL
best	NULL
of	NULL
our	NULL
knowledge	NULL
,	NULL
scattered	NULL
information	NULL
is	NULL
available	NULL
on	NULL
the	NULL
cellular	NULL
source	NULL
(	NULL
s	NULL
)	NULL
of	NULL
released	NULL
cytokines	NULL
and	NULL
on	NULL
the	NULL
mechanism	NULL
(	NULL
s	NULL
)	NULL
regulating	NULL
nuclear	NULL
factors	NULL
activity	NULL
in	NULL
immature	NULL
B	NULL
cells	NULL
.	NULL

Therefore	NULL
,	NULL
in	NULL
this	NULL
study	NULL
,	NULL
we	NULL
investigated	NULL
whether	NULL
the	NULL
triggering	NULL
of	NULL
selected	NULL
epitopes	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
expressed	NULL
on	NULL
B	NULL
cells	NULL
at	NULL
a	NULL
distinct	NULL
stage	NULL
of	NULL
maturation	NULL
would	NULL
regulate	NULL
TNF-a	NULL
release	NULL
and	NULL
its	NULL
biological	NULL
role	NULL
.	NULL

Cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
L243	NULL
did	NULL
not	NULL
induce	NULL
TNF-a	NULL
release	NULL
by	NULL
the	NULL
pre-B	NULL
cells	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
,	NULL
although	NULL
it	NULL
significantly	NULL
(	NULL
P	NULL
<	NULL
0.05	NULL
)	NULL
up-regulated	NULL
,	NULL
in	NULL
a	NULL
time-and	NULL
dose-dependent	NULL
manner	NULL
,	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
by	NULL
B	NULL
cells	NULL
Ri-l	NULL
,	NULL
Ci-1	NULL
,	NULL
and	NULL
Sc-1	NULL
,	NULL
in	NULL
the	NULL
intermediate	NULL
stage	NULL
of	NULL
maturation	NULL
,	NULL
and	NULL
by	NULL
the	NULL
less	NULL
immature	NULL
B	NULL
cell	NULL
Raji	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
PMA	NULL
stimulation	NULL
induced	NULL
and/or	NULL
enhanced	NULL
TNF-a	NULL
release	NULL
by	NULL
all	NULL
B	NULL
cells	NULL
investigated	NULL
.	NULL

Therefore	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
TNF-a	NULL
release	NULL
that	NULL
we	NULL
observed	NULL
with	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
cells	NULL
is	NULL
likely	NULL
not	NULL
to	NULL
reflect	NULL
a	NULL
constitutive	NULL
inability	NULL
of	NULL
pre-B	NULL
cells	NULL
to	NULL
synthesize	NULL
TNF-a	NULL
but	NULL
rather	NULL
suggests	NULL
that	NULL
the	NULL
capacity	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
to	NULL
regulate	NULL
TNF-a	NULL
release	NULL
is	NULL
restricted	NULL
to	NULL
discrete	NULL
stages	NULL
of	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Consistent	NULL
with	NULL
this	NULL
assumption	NULL
is	NULL
our	NULL
previous	NULL
demonstration	NULL
that	NULL
mAb	NULL
L243	NULL
enhanced	NULL
TNF-a	NULL
release	NULL
by	NULL
mature	NULL
EBV+B	NULL
cells	NULL
JY	NULL
(	NULL
8	NULL
)	NULL
and	NULL
the	NULL
demonstration	NULL
by	NULL
Northern	NULL
blot	NULL
analysis	NULL
that	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
of	NULL
pre-B	NULL
cells	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
were	NULL
not	NULL
affected	NULL
by	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
for	NULL
different	NULL
times	NULL
,	NULL
whereas	NULL
they	NULL
increased	NULL
after	NULL
their	NULL
treatment	NULL
with	NULL
PMA	NULL
with	NULL
a	NULL
kinetic	NULL
of	NULL
increase	NULL
and	NULL
to	NULL
an	NULL
extent	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
for	NULL
Raji	NULL
cells	NULL
.	NULL

Time	NULL
course	NULL
analysis	NULL
of	NULL
TNF-a	NULL
mRNA	NULL
on	NULL
Raji	NULL
cells	NULL
demonstrated	NULL
that	NULL
the	NULL
up-regulation	NULL
of	NULL
TNF-a	NULL
release	NULL
was	NULL
preceded	NULL
by	NULL
an	NULL
increase	NULL
in	NULL
the	NULL
levels	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
that	NULL
peaked	NULL
at	NULL
3	NULL
h	NULL
and	NULL
returned	NULL
to	NULL
baseline	NULL
levels	NULL
after	NULL
24	NULL
h.	NULL
This	NULL
rapid	NULL
increase	NULL
of	NULL
TNF-	NULL
«	NULL
mRNA	NULL
is	NULL
similar	NULL
to	NULL
that	NULL
observed	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
monocytic	NULL
cells	NULL
THP-1	NULL
by	NULL
staphylococcal	NULL
superantigens	NULL
TSST-1	NULL
and	NULL
staphylococcal	NULL
enterotoxin	NULL
B	NULL
(	NULL
26	NULL
)	NULL
,	NULL
and	NULL
it	NULL
strongly	NULL
suggests	NULL
a	NULL
transcriptional	NULL
regulation	NULL
of	NULL
TNF-	NULL
«	NULL
gene	NULL
expression	NULL
,	NULL
which	NULL
was	NULL
A	NULL
Nalm-6	NULL
BV173	NULL
8	NULL
o	NULL
500g	NULL
,	NULL
,	NULL
_	NULL
&	NULL
_	NULL
50	NULL
ca	NULL
$	NULL
0	NULL
P	NULL
i	NULL
&	NULL
o	NULL
34	NULL
iE	NULL
mab	NULL
L243	NULL
;	NULL
bol	NULL
pl	NULL
y	NULL
D	NULL
a	NULL
I	NULL
g	NULL
a	NULL
&	NULL
L	NULL
gold	NULL
xB	NULL
oligo	NULL
-	NULL
£	NULL
s	NULL
.	NULL

4	NULL
r	NULL
Cell	NULL
extracts	NULL
+	NULL
4	NULL
+	NULL
+	NULL
£04	NULL
+	NULL
+	NULL
+	NULL
P	NULL
+	NULL
_	NULL
a	NULL
``	NULL
bVU	NULL
-	NULL
=~u=¥U-	NULL
o=	NULL
a	NULL
|	NULL
a	NULL
»	NULL
@	NULL
us	NULL
GB	NULL
-	NULL
WB	NULL
«	NULL
«	NULL
@	NULL
@	NULL
»	NULL
@	NULL
t	NULL
~	NULL
>	NULL
was	NULL
we	NULL
wm	NULL
ao	NULL
|	NULL
C	NULL
l	NULL
BV173	NULL
‘	NULL
Nalm-6	NULL
extracts	NULL
|	NULL
-	NULL
+	NULL
+	NULL
+	NULL
&	NULL
Po	NULL
&	NULL
Fv	NULL
+	NULL
pprnnnrtt1	NULL
Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
B	NULL
©	NULL
o	NULL
#	NULL
n	NULL
3	NULL
2	NULL
_	NULL
-	NULL
€0B	NULL
2	NULL
l	NULL
.	NULL

€	NULL
a_	NULL
_¢°	NULL
6	NULL
40	NULL
Bo	NULL
fj	NULL
i	NULL
g	NULL
s	NULL
4	NULL
&	NULL
mAb	NULL
1.243	NULL
+	NULL
-	NULL
-	NULL
+	NULL
+	NULL
+	NULL
+	NULL
Po	NULL
F	NULL
cold	NULL
AP-1	NULL
oligo	NULL
T	NULL
:	NULL
Cell	NULL
extracts	NULL
aa	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
+	NULL
all	NULL
a	NULL
by	NULL
as	NULL
a	NULL
ud	NULL
&	NULL
c	NULL
@	NULL
@	NULL
H	NULL
W	NULL
--	NULL
#	NULL
-	NULL
-	NULL
-	NULL
m	NULL
-	NULL
H	NULL
+	NULL
_+	NULL
+0	NULL
+0	NULL
+	NULL
+	NULL
np	NULL
|	NULL
tng	NULL
as	NULL
be	NULL
bo	NULL
be	NULL
b4	NULL
be	NULL
be	NULL
ba	NULL
bd	NULL
bd	NULL
#	NULL
4	NULL
N	NULL
as	NULL
Fig	NULL
.	NULL

7	NULL
.	NULL

-	NULL
Analysis	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
activation	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

Cultures	NULL
of	NULL
Nalm-6	NULL
,	NULL
BV173	NULL
,	NULL
Ri-1	NULL
,	NULL
Ci-l	NULL
,	NULL
Sc-1	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
the	NULL
anti-HLA-DR	NULL
mAb	NULL
L243	NULL
(	NULL
10	NULL
ug/m	NULL
!	NULL
)	NULL

.	NULL

After	NULL
a	NULL
1	NULL
-h	NULL
incubation	NULL
at	NULL
37°C	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
frozen	NULL
at	NULL
-80°C	NULL
.	NULL

Nuclear	NULL
extracts	NULL
and	NULL
EMSA	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
in	NULL
``	NULL
Materials	NULL
and	NULL
Methods	NULL
``	NULL
using	NULL
oligonucleotides	NULL
containing	NULL
NF-B	NULL
(	NULL
A	NULL
)	NULL
,	NULL
AP-1	NULL
(	NULL
B	NULL
)	NULL
,	NULL
and	NULL
Spt	NULL
(	NULL
C	NULL
)	NULL
sequences	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
mAb	NULL
.	NULL

One	NULL
representative	NULL
experiment	NULL
of	NULL
three	NULL
is	NULL
shown	NULL
.	NULL

found	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
the	NULL
increase	NULL
in	NULL
TNF-a	NULL
mRNA	NULL
levels	NULL
in	NULL
THP-1	NULL
cells	NULL
(	NULL
26	NULL
)	NULL
.	NULL

Nevertheless	NULL
,	NULL
posttranscriptional	NULL
mechanisms	NULL
participate	NULL
in	NULL
TNF-a	NULL
biosynthesis	NULL
(	NULL
27	NULL
)	NULL
and	NULL
their	NULL
possible	NULL
involvement	NULL
in	NULL
TNF-a	NULL
release	NULL
by	NULL
B	NULL
cells	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
by	NULL
mAb	NULL
L243	NULL
can	NULL
not	NULL
be	NULL
presently	NULL
ruled	NULL
out	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
induced	NULL
homotypic	NULL
aggregation	NULL
of	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-1	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
but	NULL
not	NULL
of	NULL
Naim-6	NULL
585	NULL
586	NULL
-	NULL
HLA-DR	NULL
Antigen-mediated	NULL
TNF-a	NULL
Release	NULL
in	NULL
B	NULL
Cells	NULL
3	NULL
3	NULL
o	NULL
-	NULL
&	NULL
3	NULL
2	NULL
98	NULL
u	NULL
AEIm	NULL
Additives	NULL
2	NULL
_	NULL
E	NULL
Eﬁ	NULL
-	NULL
E	NULL
a	NULL
?	NULL

<	NULL
4	NULL
2	NULL
<	NULL
4	NULL
t	NULL
E	NULL
E	NULL
§	NULL
E	NULL
E	NULL
§	NULL
Cell	NULL
extracts	NULL
-	NULL
4	NULL
#	NULL
0040	NULL
40	NULL
4	NULL
+	NULL
#	NULL
Bound	NULL
#	NULL
U	NULL
«	NULL
fad	NULL
Free	NULL
Fig	NULL
.	NULL

8	NULL
.	NULL

Inhibition	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
anti-TNF-	NULL
«	NULL
neutralizing	NULL
polyclonal	NULL
antibody	NULL
.	NULL

Cultures	NULL
of	NULL
Nalm-6	NULL
and	NULL
Raji	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10°	NULL
)	NULL
were	NULL
supplemented	NULL
with	NULL
the	NULL
anti-HLA-DR	NULL
mAb	NULL
L243	NULL
(	NULL
10	NULL
ug/ml	NULL
)	NULL
used	NULL
alone	NULL
or	NULL
in	NULL
combination	NULL
with	NULL
anti-TNF-	NULL
«	NULL
neutralizing	NULL
polyclonal	NULL
antibody	NULL
(	NULL
blocking	NULL
activity	NULL
,	NULL
1000	NULL
units	NULL
of	NULL
TNF-a	NULL
)	NULL
.	NULL

After	NULL
a	NULL
1-h	NULL
incubation	NULL
at	NULL
37°C	NULL
,	NULL
cells	NULL
were	NULL
washed	NULL
three	NULL
times	NULL
with	NULL
PBS	NULL
and	NULL
frozen	NULL
at	NULL
-80°C	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
incubated	NULL
under	NULL
the	NULL
same	NULL
experimental	NULL
conditions	NULL
but	NULL
without	NULL
mAb	NULL
or	NULL
neutralizing	NULL
antibody	NULL
.	NULL

and	NULL
BV173	NULL
cells	NULL
.	NULL

This	NULL
discrepancy	NULL
is	NULL
not	NULL
due	NULL
to	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
autocrine	NULL
effect	NULL
of	NULL
released	NULL
TNF-a	NULL
on	NULL
pre-B	NULL
cells	NULL
because	NULL
TNF-a	NULL
secreted	NULL
by	NULL
Ri-l	NULL
,	NULL
Ci-l	NULL
,	NULL
Sc-l	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
was	NULL
found	NULL
not	NULL
to	NULL
be	NULL
responsible	NULL
for	NULL
their	NULL
homotypic	NULL
aggregation	NULL
.	NULL

Moreover	NULL
,	NULL
Nalm-6	NULL
cells	NULL
can	NULL
be	NULL
induced	NULL
to	NULL
aggregate	NULL
by	NULL
anti-CD9	NULL
and	NULL
anti-very	NULL
late	NULL
antigen	NULL
mAbs	NULL
(	NULL
28	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
they	NULL
are	NULL
not	NULL
intrinsically	NULL
unable	NULL
to	NULL
aggregate	NULL
but	NULL
rather	NULL
lack	NULL
this	NULL
capacity	NULL
after	NULL
the	NULL
engagement	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

The	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
did	NULL
not	NULL
affect	NULL
the	NULL
proliferation	NULL
of	NULL
B	NULL
cells	NULL
investigated	NULL
.	NULL

This	NULL
information	NULL
is	NULL
at	NULL
variance	NULL
with	NULL
data	NULL
we	NULL
obtained	NULL
previously	NULL
with	NULL
EBV	NULL
+B	NULL
cells	NULL
JY	NULL
,	NULL
which	NULL
are	NULL
significantly	NULL
growth-inhibited	NULL
by	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
(	NULL
8	NULL
)	NULL
.	NULL

These	NULL
data	NULL
suggest	NULL
that	NULL
intracellular	NULL
signal	NULL
(	NULL
s	NULL
)	NULL
regulating	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
are	NULL
distinct	NULL
from	NULL
those	NULL
regulating	NULL
cell	NULL
proliferation	NULL
.	NULL

Neither	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
nor	NULL
the	NULL
regulation	NULL
of	NULL
cell	NULL
proliferation	NULL
or	NULL
homotypic	NULL
cell	NULL
aggregation	NULL
correlated	NULL
with	NULL
cell	NULL
surface	NULL
level	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
staining	NULL
of	NULL
B	NULL
cells	NULL
under	NULL
study	NULL
with	NULL
mAb	NULL
L243	NULL
detected	NULL
the	NULL
highest	NULL
expression	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
Nalm-6	NULL
cells	NULL
.	NULL

The	NULL
lack	NULL
of	NULL
effect	NULL
of	NULL
the	NULL
anti-HLA-DR	NULL
mAb	NULL
2.06	NULL
in	NULL
the	NULL
investigated	NULL
phenomena	NULL
and	NULL
its	NULL
reactivity	NULL
with	NULL
B	NULL
cells	NULL
under	NULL
study	NULL
,	NULL
which	NULL
was	NULL
similar	NULL
to	NULL
that	NULL
of	NULL
mAb	NULL
L243	NULL
,	NULL
strongly	NULL
suggest	NULL
that	NULL
selected	NULL
epitopes	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
transduce	NULL
intracellular	NULL
signals	NULL
leading	NULL
to	NULL
the	NULL
observed	NULL
phenomena	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
cross-inhibition	NULL
experiments	NULL
demonstrated	NULL
that	NULL
mAb	NULL
L243	NULL
and	NULL
mAb	NULL
2.06	NULL
recognize	NULL
close	NULL
but	NULL
not	NULL
identical	NULL
epitopes	NULL
of	NULL
the	NULL
HLA-DR	NULL
molecule	NULL
(	NULL
data	NULL
not	NULL
shown	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
mAb	NULL
2.06	NULL
failed	NULL
to	NULL
induce	NULL
TNF-a	NULL
release	NULL
by	NULL
the	NULL
EBV	NULL
+B	NULL
cells	NULL
JY	NULL
(	NULL
8	NULL
)	NULL
and	NULL
did	NULL
not	NULL
inhibit	NULL
the	NULL
proliferation	NULL
of	NULL
JY	NULL
cells	NULL
(	NULL
8	NULL
)	NULL
and	NULL
of	NULL
EBV+B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
cells	NULL
(	NULL
4	NULL
)	NULL
.	NULL

To	NULL
further	NULL
investigate	NULL
intracellular	NULL
signals	NULL
induced	NULL
by	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
B	NULL
cells	NULL
at	NULL
different	NULL
stages	NULL
of	NULL
maturation	NULL
,	NULL
we	NULL
analyzed	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
binding	NULL
factors	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
,	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
.	NULL

NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
are	NULL
activated	NULL
in	NULL
specific	NULL
stages	NULL
of	NULL
B-cell	NULL
maturation	NULL
(	NULL
12	NULL
,	NULL
29	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
NF-	NULL
«	NULL
B	NULL
has	NULL
been	NULL
reported	NULL
to	NULL
be	NULL
a	NULL
constitu-tively	NULL
active	NULL
nuclear	NULL
protein	NULL
in	NULL
mature	NULL
B	NULL
cells	NULL
,	NULL
whereas	NULL
in	NULL
pre-B	NULL
cells	NULL
,	NULL
it	NULL
is	NULL
activated	NULL
only	NULL
after	NULL
treatment	NULL
with	NULL
PMA	NULL
or	NULL
lipopolysaccharide	NULL
(	NULL
30	NULL
)	NULL
.	NULL

The	NULL
state	NULL
of	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
the	NULL
production	NULL
of	NULL
TNF-a	NULL
by	NULL
mature	NULL
B	NULL
cells	NULL
seem	NULL
to	NULL
be	NULL
strictly	NULL
interdependent	NULL
(	NULL
30	NULL
)	NULL
;	NULL
in	NULL
fact	NULL
,	NULL
TNF-a	NULL
release	NULL
by	NULL
mature	NULL
B	NULL
cells	NULL
is	NULL
under	NULL
transcriptional	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
31	NULL
)	NULL
,	NULL
and	NULL
TNF-a	NULL
is	NULL
a	NULL
potent	NULL
activator	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
31	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
32	NULL
)	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
observations	NULL
suggested	NULL
that	NULL
TNF-	NULL
«	NULL
production	NULL
by	NULL
mature	NULL
B	NULL
cells	NULL
provides	NULL
a	NULL
permanent	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
activation	NULL
through	NULL
an	NULL
autostimulatory	NULL
regulatory	NULL
loop	NULL
(	NULL
31	NULL
)	NULL
.	NULL

Moreover	NULL
,	NULL
we	NULL
have	NULL
recently	NULL
demonstrated	NULL
that	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
is	NULL
already	NULL
detectable	NULL
15	NULL
min	NULL
after	NULL
the	NULL
cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
on	NULL
Raji	NULL
cells	NULL
(	NULL
33	NULL
)	NULL
.	NULL

These	NULL
observations	NULL
strongly	NULL
suggest	NULL
the	NULL
lack	NULL
of	NULL
an	NULL
NF-	NULL
«	NULL
B-independent	NULL
TNF-a	NULL
gene	NULL
expression	NULL
mediated	NULL
by	NULL
the	NULL
cross-linking	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
.	NULL

The	NULL
data	NULL
reported	NULL
in	NULL
our	NULL
study	NULL
show	NULL
that	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
up-regulates	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
in	NULL
B	NULL
cells	NULL
at	NULL
intermediate	NULL
and	NULL
mature	NULL
stages	NULL
of	NULL
differentiation	NULL
but	NULL
not	NULL
in	NULL
pre-B	NULL
cells	NULL
(	NULL
Fig	NULL
.	NULL

7	NULL
)	NULL
and	NULL
that	NULL
secreted	NULL
TNF-a	NULL
is	NULL
responsible	NULL
for	NULL
such	NULL
phenomena	NULL
.	NULL

Thus	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
activation	NULL
that	NULL
we	NULL
observed	NULL
in	NULL
Nalm-6	NULL
and	NULL
BV173	NULL
cells	NULL
is	NULL
likely	NULL
due	NULL
to	NULL
the	NULL
inability	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
to	NULL
induce	NULL
TNF-a	NULL
release	NULL
by	NULL
pre-B	NULL
cells	NULL
.	NULL

Together	NULL
,	NULL
these	NULL
data	NULL
demonstrate	NULL
that	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
can	NULL
modulate	NULL
the	NULL
autocrine	NULL
loop	NULL
involving	NULL
TNF-a-regulated	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
during	NULL
B-cell	NULL
maturation	NULL
.	NULL

The	NULL
involvement	NULL
of	NULL
an	NULL
autocrine	NULL
loop	NULL
sustaining	NULL
NF-	NULL
«	NULL
B	NULL
and	NULL
AP-1	NULL
activation	NULL
in	NULL
monocytoid	NULL
cells	NULL
has	NULL
been	NULL
reported	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
using	NULL
TSST-1	NULL
,	NULL
which	NULL
binds	NULL
outside	NULL
the	NULL
antigen	NULL
binding	NULL
groove	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
(	NULL
34	NULL
)	NULL
,	NULL
Trede	NULL
et	NULL
a/	NULL
.	NULL

have	NULL
reported	NULL
a	NULL
TNF-a-dependent	NULL
up-regulation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
(	NULL
22	NULL
)	NULL
and	NULL
AP-1	NULL
(	NULL
35	NULL
)	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

It	NULL
is	NULL
,	NULL
however	NULL
,	NULL
noteworthy	NULL
that	NULL
TSST-1	NULL
and	NULL
staphylococcal	NULL
enterotoxin	NULL
B	NULL
do	NULL
not	NULL
regulate	NULL
TNF-a	NULL
release	NULL
and	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
by	NULL
B	NULL
cells	NULL
(	NULL
8	NULL
,	NULL
36	NULL
)	NULL
,	NULL
suggesting	NULL
a	NULL
differential	NULL
role	NULL
of	NULL
the	NULL
two	NULL
stimuli	NULL
in	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
by	NULL
B	NULL
cells	NULL
.	NULL

Cell	NULL
Growth	NULL
&	NULL
Differentiation	NULL
Table	NULL
1	NULL
-	NULL
Effect	NULL
of	NULL
the	NULL
anti-HLA-DR	NULL
mAb	NULL
L243	NULL
or	NULL
mAb	NULL
2.06	NULL
on	NULL
B-cell	NULL
proliferation	NULL
and	NULL
homotypic	NULL
aggregation	NULL
Cell	NULL
uptake®	NULL
Homotypic	NULL
aggregation	NULL
``	NULL
Medium	NULL
L243	NULL
2.06	NULL
Medium	NULL
L243	NULL
2.06	NULL
Naim-6	NULL
13,800	NULL
+	NULL
2,420	NULL
13,900	NULL
+	NULL
1,970	NULL
13,100	NULL
+	NULL
1,280	NULL
-	NULL
-	NULL
Ri-l	NULL
13,000	NULL
+	NULL
2,600	NULL
11,130	NULL
+	NULL
3,300	NULL
12,100	NULL
+	NULL
2,500	NULL
-	NULL
++	NULL
Ci-l	NULL
7,060	NULL
*	NULL
3,870	NULL
5,820	NULL
+	NULL
3,570	NULL
6,090	NULL
+	NULL
3,570	NULL
-	NULL
++	NULL
Sc-l	NULL
9,650	NULL
+	NULL
2,980	NULL
9,300	NULL
+	NULL
2,260	NULL
9,690	NULL
+	NULL
2,710	NULL
-	NULL
++	NULL
Raji	NULL
7,570	NULL
*	NULL
1,370	NULL
7,880	NULL
*	NULL
1,660	NULL
7,220	NULL
*	NULL
435	NULL
-	NULL
++	NULL
*	NULL
PH	NULL
}	NULL
thymidine	NULL
uptake	NULL
was	NULL
measured	NULL
after	NULL
a	NULL
24-h	NULL
incubation	NULL
with	NULL
or	NULL
without	NULL
specific	NULL
mAb	NULL
.	NULL

Data	NULL
are	NULL
expressed	NULL
in	NULL
cpm	NULL
and	NULL
represent	NULL
the	NULL
mean	NULL
+	NULL
SD	NULL
of	NULL
three	NULL
experiments	NULL
.	NULL

®	NULL
Cell	NULL
aggregation	NULL
was	NULL
scored	NULL
after	NULL
a	NULL
1-h	NULL
incubation	NULL
.	NULL

-	NULL
,	NULL
no	NULL
aggregation	NULL
;	NULL
++	NULL
,	NULL
>	NULL
50	NULL
%	NULL
aggregated	NULL
cells	NULL
.	NULL

Table	NULL
2	NULL
Classification	NULL
of	NULL
B	NULL
cells	NULL
under	NULL
study	NULL
Cell	NULL
line	NULL
Type	NULL
Ref	NULL
.	NULL

Nalm-6	NULL
Pre-B	NULL
leukemia	NULL
17	NULL
BV173	NULL
Pre-B	NULL
leukemia	NULL
(	NULL
Ph'-positive	NULL
)	NULL
18	NULL
Ri-l	NULL
Small	NULL
lymphocytic	NULL
lymphoma	NULL
15	NULL
Cit	NULL
Non-convoluted	NULL
cell	NULL
lymphoblastic	NULL
tymphoma	NULL
15	NULL
Sc-t	NULL
Small	NULL
cleaved	NULL
cell	NULL
follicular	NULL
lymphoma	NULL
15	NULL
Raji	NULL
Burkitt	NULL
16	NULL
The	NULL
release	NULL
of	NULL
TNF-a	NULL
by	NULL
mature	NULL
B	NULL
cells	NULL
after	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
may	NULL
have	NULL
profound	NULL
implications	NULL
in	NULL
antigen-specific	NULL
B	NULL
cell-T	NULL
cell	NULL
interactions	NULL
.	NULL

In	NULL
fact	NULL
,	NULL
during	NULL
B	NULL
cell-T	NULL
cell	NULL
cognate	NULL
interactions	NULL
,	NULL
CD4	NULL
expressed	NULL
on	NULL
T	NULL
cells	NULL
induces	NULL
HLA-DR	NULL
cross-linking	NULL
,	NULL
leading	NULL
to	NULL
stable	NULL
B	NULL
cell-T	NULL
cell	NULL
interaction	NULL
and	NULL
to	NULL
T-cell	NULL
activation	NULL
(	NULL
37	NULL
)	NULL
,	NULL
enhancing	NULL
the	NULL
efficiency	NULL
of	NULL
antigen	NULL
presentation	NULL
to	NULL
T	NULL
cells	NULL
.	NULL

in	NULL
addition	NULL
,	NULL
TNF-a	NULL
is	NULL
involved	NULL
in	NULL
the	NULL
development	NULL
of	NULL
the	NULL
germinal	NULL
center	NULL
(	NULL
38	NULL
)	NULL
;	NULL
thus	NULL
,	NULL
it	NULL
can	NULL
be	NULL
speculated	NULL
that	NULL
B-cell	NULL
migration	NULL
into	NULL
the	NULL
follicle	NULL
after	NULL
B	NULL
cell-T	NULL
cell	NULL
interaction	NULL
and	NULL
the	NULL
activation	NULL
of	NULL
the	NULL
NF-	NULL
«	NULL
kB/TNF-	NULL
«	NULL
loop	NULL
may	NULL
contribute	NULL
to	NULL
the	NULL
development	NULL
of	NULL
the	NULL
germinal	NULL
center	NULL
.	NULL

Little	NULL
is	NULL
known	NULL
about	NULL
the	NULL
effects	NULL
of	NULL
TNF-	NULL
«	NULL
on	NULL
B-cell	NULL
development	NULL
(	NULL
39	NULL
)	NULL
.	NULL

Our	NULL
present	NULL
data	NULL
suggest	NULL
that	NULL
TNF-a	NULL
released	NULL
by	NULL
immature	NULL
B	NULL
cells	NULL
can	NULL
play	NULL
a	NULL
significantly	NULL
functional	NULL
role	NULL
by	NULL
regulating	NULL
the	NULL
NF-kB	NULL
and	NULL
AP-1	NULL
binding	NULL
activities	NULL
,	NULL
which	NULL
are	NULL
involved	NULL
in	NULL
the	NULL
regulation	NULL
of	NULL
different	NULL
genes	NULL
relevant	NULL
to	NULL
B-cell	NULL
development	NULL
(	NULL
31	NULL
)	NULL
.	NULL

In	NULL
addition	NULL
,	NULL
the	NULL
lack	NULL
of	NULL
TNF-a	NULL
release	NULL
by	NULL
pre-B	NULL
cells	NULL
suggests	NULL
that	NULL
TNF-a	NULL
might	NULL
be	NULL
important	NULL
for	NULL
B-cell	NULL
development	NULL
from	NULL
a	NULL
specific	NULL
stage	NULL
of	NULL
maturation	NULL
on	NULL
.	NULL

In	NULL
view	NULL
of	NULL
the	NULL
latter	NULL
considerations	NULL
,	NULL
it	NULL
can	NULL
be	NULL
envisaged	NULL
that	NULL
HLA-DR	NULL
antigens	NULL
may	NULL
play	NULL
a	NULL
critical	NULL
role	NULL
in	NULL
B-cell	NULL
differentiation	NULL
by	NULL
regulating	NULL
the	NULL
release	NULL
of	NULL
TNF-a	NULL
in	NULL
discrete	NULL
stages	NULL
of	NULL
B-cell	NULL
maturation	NULL
.	NULL

The	NULL
understanding	NULL
of	NULL
TNF-a	NULL
gene	NULL
expression	NULL
during	NULL
B-cell	NULL
maturation	NULL
and	NULL
HLA-DR	NULL
molecule-mediated	NULL
signal	NULL
transduction	NULL
could	NULL
lead	NULL
to	NULL
define	NULL
new	NULL
approaches	NULL
to	NULL
the	NULL
control	NULL
of	NULL
normal	NULL
and	NULL
neoplastic	NULL
B-cell	NULL
differentiation	NULL
.	NULL

Materials	NULL
and	NULL
Methods	NULL
Cells	NULL
.	NULL

The	NULL
human	NULL
B-cell	NULL
fines	NULL
Nalm-6	NULL
(	NULL
17	NULL
)	NULL
,	NULL
BV178	NULL
(	NULL
18	NULL
)	NULL
,	NULL
Ri-1	NULL
,	NULL
Ci-1	NULL
,	NULL
Sc-1	NULL
(	NULL
15	NULL
)	NULL
,	NULL
and	NULL
Raji	NULL
(	NULL
Ref	NULL
.	NULL

16	NULL
;	NULL
Table	NULL
2	NULL
)	NULL
were	NULL
grown	NULL
in	NULL
RPMI	NULL
1640	NULL
(	NULL
Flow	NULL
Laboratories	NULL
Inc.	NULL
,	NULL
McLean	NULL
,	NULL
VA	NULL
)	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
heat-inactivated	NULL
FCS	NULL
(	NULL
Flow	NULL
Laboratories	NULL
,	NULL
Inc.	NULL
)	NULL
and	NULL
2	NULL
mm	NULL
u-glutamine	NULL
.	NULL

All	NULL
cell	NULL
lines	NULL
tested	NULL
negative	NULL
for	NULL
mycoplasma	NULL
contamination	NULL
.	NULL

mAbs	NULL
and	NULL
Reagents	NULL
.	NULL

The	NULL
anti-HLA-DR	NULL
mAb	NULL
L243	NULL
and	NULL
mAb	NULL
2.06	NULL
(	NULL
8	NULL
)	NULL
were	NULL
purchased	NULL
from	NULL
American	NULL
Type	NULL
Culture	NULL
Collection	NULL
(	NULL
Rockville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

mAbs	NULL
were	NULL
purified	NULL
from	NULL
ascitic	NULL
fluid	NULL
by	NULL
sequential	NULL
purification	NULL
with	NULL
caprylic	NULL
acid	NULL
and	NULL
ammonium	NULL
sulfate	NULL
(	NULL
8	NULL
)	NULL
.	NULL

The	NULL
purity	NULL
of	NULL
mAb	NULL
preparations	NULL
was	NULL
moni-	NULL
tored	NULL
by	NULL
SDS-PAGE	NULL
(	NULL
40	NULL
)	NULL
under	NULL
reducing	NULL
and	NULL
nonreducing	NULL
conditions	NULL
.	NULL

No	NULL
lipopolysaccharide	NULL
was	NULL
detected	NULL
in	NULL
mAb	NULL
preparations	NULL
by	NULL
the	NULL
Limulus	NULL
amoe-bocyte	NULL
lysate	NULL
test	NULL
(	NULL
sensitivity	NULL
,	NULL
<	NULL
1	NULL
ng/ml	NULL
;	NULL
BioWhittaker	NULL
,	NULL
Inc.	NULL
,	NULL
Walkersville	NULL
,	NULL
MD	NULL
)	NULL
.	NULL

PMA	NULL
was	NULL
purchased	NULL
from	NULL
Sigma	NULL
Chemical	NULL
Co.	NULL
(	NULL
St.	NULL
Louis	NULL
,	NULL
MO	NULL
)	NULL
.	NULL

Polyclonal	NULL
rabbit	NULL
antihuman	NULL
TNF-a	NULL
neutralizing	NULL
antibody	NULL
was	NULL
purchased	NULL
from	NULL
Genzyme	NULL
Corporation	NULL
(	NULL
Cambridge	NULL
,	NULL
MA	NULL
}	NULL
.	NULL

In	NULL
all	NULL
experimental	NULL
procedures	NULL
,	NULL
10	NULL
pl	NULL
of	NULL
the	NULL
latter	NULL
antibody	NULL
were	NULL
used	NULL
(	NULL
able	NULL
to	NULL
neutralize	NULL
1000	NULL
units	NULL
of	NULL
TNF-a	NULL
)	NULL
.	NULL

Serological	NULL
and	NULL
Proliferation	NULL
Assays	NULL
.	NULL

The	NULL
double	NULL
determinant	NULL
im-munoassay	NULL
to	NULL
measure	NULL
TNF-	NULL
«	NULL
was	NULL
performed	NULL
using	NULL
an	NULL
ELISA	NULL
kit	NULL
purchased	NULL
from	NULL
Quantikine	NULL
RD	NULL
(	NULL
R	NULL
&	NULL
D	NULL
Systems	NULL
,	NULL
Minneapolis	NULL
,	NULL
MN	NULL
)	NULL
.	NULL

Indirect	NULL
immunofluorescence	NULL
analysis	NULL
and	NULL
flow	NULL
cytometry	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

For	NULL
proliferation	NULL
assays	NULL
,	NULL
Nalm-6	NULL
,	NULL
Ri-t	NULL
,	NULL
Ci-I	NULL
,	NULL
Sc-I	NULL
,	NULL
and	NULL
Raji	NULL
cells	NULL
were	NULL
cultured	NULL
(	NULL
2	NULL
x	NULL
10°	NULL
cells/well	NULL
}	NULL
in	NULL
96-well	NULL
round-bottomed	NULL
plates	NULL
(	NULL
Costar	NULL
Corp.	NULL
,	NULL
Cambridge	NULL
,	NULL
MA	NULL
)	NULL
in	NULL
200	NULL
Ll	NULL
of	NULL
RPMI	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
2	NULL
mm	NULL
u-glutamine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ug/ml	NULL
mAb	NULL
L243	NULL
or	NULL
10	NULL
ug/ml	NULL
mAb	NULL
2.06	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
incubated	NULL
under	NULL
similar	NULL
experimental	NULL
conditions	NULL
without	NULL
stimuli	NULL
.	NULL

All	NULL
the	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
triplicate	NULL
.	NULL

Cultures	NULL
were	NULL
incubated	NULL
for	NULL
due	NULL
time	NULL
at	NULL
37°C	NULL
in	NULL
a	NULL
5	NULL
%	NULL
CO	NULL
,	NULL
humidified	NULL
atmosphere	NULL
and	NULL
were	NULL
pulsed	NULL
with	NULL
1	NULL
uCi/well	NULL
(	NULL
Amersham	NULL
International	NULL
,	NULL
Ayles-bury	NULL
,	NULL
United	NULL
Kingdom	NULL
)	NULL
for	NULL
4	NULL
h.	NULL
Then	NULL
cultures	NULL
were	NULL
harvested	NULL
on	NULL
glass	NULL
fiber	NULL
strips	NULL
,	NULL
and	NULL
incorporation	NULL
was	NULL
measured	NULL
by	NULL
a	NULL
MATRIX	NULL
96	NULL
Direct	NULL
Beta	NULL
Counter	NULL
(	NULL
Packard	NULL
,	NULL
Meridien	NULL
,	NULL
CT	NULL
)	NULL
.	NULL

Cell	NULL
Aggregation	NULL
Assays	NULL
.	NULL

Cell	NULL
aggregation	NULL
assays	NULL
were	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
.	NULL

Briefly	NULL
,	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
were	NULL
seeded	NULL
in	NULL
8-well	NULL
Lab-Tech	NULL
Chamber	NULL
Slides	NULL
(	NULL
Nunc	NULL
Inc.	NULL
,	NULL
Naperville	NULL
,	NULL
IL	NULL
)	NULL
in	NULL
200	NULL
Ll	NULL
of	NULL
RPME	NULL
1640	NULL
supplemented	NULL
with	NULL
10	NULL
%	NULL
FCS	NULL
and	NULL
2	NULL
mm	NULL
u-glutamine	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
10	NULL
ug/ml	NULL
mAb	NULL
L243	NULL
or	NULL
10	NULL
pg/ml	NULL
mAb	NULL
2.06	NULL
.	NULL

Control	NULL
cultures	NULL
were	NULL
incubated	NULL
under	NULL
similar	NULL
experimental	NULL
conditions	NULL
without	NULL
stimuli	NULL
.	NULL

All	NULL
experiments	NULL
were	NULL
performed	NULL
in	NULL
duplicate	NULL
.	NULL

Slides	NULL
were	NULL
scored	NULL
independently	NULL
by	NULL
two	NULL
investigators	NULL
by	NULL
using	NULL
an	NULL
inverted	NULL
microscope	NULL
.	NULL

RNA	NULL
Extraction	NULL
and	NULL
Northern	NULL
Blotting	NULL
.	NULL

Total	NULL
RNA	NULL
was	NULL
extracted	NULL
from	NULL
investigated	NULL
cells	NULL
(	NULL
1	NULL
x	NULL
10	NULL
``	NULL
)	NULL
as	NULL
described	NULL
(	NULL
41	NULL
)	NULL
by	NULL
using	NULL
the	NULL
RNAfast	NULL
Isolation	NULL
System	NULL
(	NULL
Molecular	NULL
Systems	NULL
,	NULL
San	NULL
Diego	NULL
,	NULL
CA	NULL
}	NULL
.	NULL

RNA	NULL
(	NULL
10	NULL
ug	NULL
)	NULL
was	NULL
size-fraction-ated	NULL
on	NULL
denaturing	NULL
1	NULL
%	NULL
agarose-formaldehyde	NULL
gel	NULL
and	NULL
transferred	NULL
overnight	NULL
to	NULL
Hybond-N	NULL
hybridization	NULL
transfer	NULL
membrane	NULL
(	NULL
Amersham	NULL
)	NULL
.	NULL

cDNA	NULL
probe	NULL
for	NULL
TNF-a	NULL
(	NULL
kindly	NULL
provided	NULL
by	NULL
Dr.	NULL
William	NULL
Jacob	NULL
,	NULL
Genetic	NULL
Therapy	NULL
,	NULL
Inc.	NULL
,	NULL
Gaith-ersburg	NULL
,	NULL
MD	NULL
)	NULL
was	NULL
a	NULL
0.7-kb	NULL
fragment	NULL
cut	NULL
from	NULL
pT2	NULL
plasmid	NULL
by	NULL
the	NULL
restriction	NULL
enzymes	NULL
Bill	NULL
and	NULL
Xhol	NULL
.	NULL

cDNA	NULL
probe	NULL
was	NULL
radiolabeled	NULL
with	NULL
[	NULL
a-*°PIJdCTP	NULL
{	NULL
Amersham	NULL
)	NULL
using	NULL
a	NULL
Random	NULL
Primed	NULL
DNA	NULL
Labeling	NULL
Kit	NULL
(	NULL
Boehringer	NULL
Mann-heim	NULL
,	NULL
Milan	NULL
,	NULL
Italy	NULL
)	NULL
to	NULL
a	NULL
specific	NULL
activity	NULL
of	NULL
1-3	NULL
x	NULL
10°	NULL
cpm/ug	NULL
.	NULL

Filters	NULL
were	NULL
processed	NULL
for	NULL
autoradiography	NULL
as	NULL
described	NULL
(	NULL
41	NULL
)	NULL
.	NULL

EMSA	NULL
.	NULL

EMSA	NULL
was	NULL
performed	NULL
as	NULL
described	NULL
previously	NULL
(	NULL
8	NULL
)	NULL
,	NULL
using	NULL
5	NULL
ug	NULL
of	NULL
nuclear	NULL
extract	NULL
in	NULL
the	NULL
presence	NULL
of	NULL
1	NULL
ug	NULL
of	NULL
calf	NULL
thymus	NULL
DNA	NULL
(	NULL
Sigma	NULL
)	NULL
.	NULL

Oligonucleotides	NULL
containing	NULL
the	NULL
NF-xB	NULL
,	NULL
AP-1	NULL
,	NULL
and	NULL
Sp1	NULL
recognition	NULL
sequence	NULL
(	NULL
Promega	NULL
,	NULL
Madison	NULL
,	NULL
WI	NULL
;	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
were	NULL
used	NULL
as	NULL
probes	NULL
.	NULL

Oligonucleotides	NULL
were	NULL
radiolabeled	NULL
at	NULL
5	NULL
``	NULL
end	NULL
with	NULL
[	NULL
y-*°PJATP	NULL
{	NULL
Amersham	NULL
)	NULL
and	NULL
polynucleotide	NULL
kinase	NULL
(	NULL
Promega	NULL
;	NULL
Ref	NULL
.	NULL

8	NULL
)	NULL
and	NULL
used	NULL
at	NULL
50	NULL
pmol	NULL
per	NULL
reaction	NULL
.	NULL

Nuclear	NULL
extracts	NULL
were	NULL
prepared	NULL
as	NULL
described	NULL
(	NULL
8	NULL
)	NULL
,	NULL
normalized	NULL
for	NULL
protein	NULL
levels	NULL
,	NULL
and	NULL
used	NULL
immediately	NULL
for	NULL
EMSA	NULL
on	NULL
7.5	NULL
%	NULL
polyacrylamide	NULL
gels	NULL
.	NULL

Statistical	NULL
Analysis	NULL
.	NULL

Data	NULL
were	NULL
analyzed	NULL
by	NULL
the	NULL
Student	NULL
's	NULL
paired	NULL
t	NULL
test	NULL
using	NULL
the	NULL
StatWorks	NULL
statistical	NULL
package	NULL
from	NULL
Cricket	NULL
Software	NULL
,	NULL
Inc.	NULL
(	NULL
Phil-adelphia	NULL
,	NULL
PA	NULL
)	NULL
.	NULL

Differences	NULL
with	NULL
P	NULL
<	NULL
0.05	NULL
were	NULL
considered	NULL
statistically	NULL
significant	NULL
.	NULL

587	NULL
588	NULL
-	NULL
HLA-DR	NULL
Antigen-mediated	NULL
TNF-a	NULL
Release	NULL
in	NULL
B	NULL
Cells	NULL
Acknowledgments	NULL
We	NULL
are	NULL
grateful	NULL
to	NULL
Dr.	NULL
Luigi	NULL
Del	NULL
Vecchio	NULL
(	NULL
Immunocytology	NULL
Laboratory	NULL
,	NULL
A.	NULL
Cardarelli	NULL
Hospital	NULL
,	NULL
Naples	NULL
,	NULL
Italy	NULL
)	NULL
for	NULL
his	NULL
critical	NULL
comments	NULL
and	NULL
helpful	NULL
discussion	NULL
of	NULL
the	NULL
manuscript	NULL
.	NULL

References	NULL
1	NULL
.	NULL

Mourad	NULL
,	NULL
W.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Chatila	NULL
,	NULL
T.	NULL
Engagement	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
molecules	NULL
induces	NULL
sustained	NULL
,	NULL
lymphocyte	NULL
function-associated	NULL
molecule	NULL
1-dependent	NULL
cell	NULL
adhesion	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
172	NULL
;	NULL
1513-1516	NULL
,	NULL
1990	NULL
.	NULL

2	NULL
.	NULL

Kansas	NULL
,	NULL
G.	NULL
S.	NULL
,	NULL
Cambier	NULL
,	NULL
J.	NULL
C.	NULL
,	NULL
and	NULL
Tedder	NULL
,	NULL
T.	NULL
F.	NULL
CD4	NULL
binding	NULL
to	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
iI	NULL
antigens	NULL
induces	NULL
LFA-1-dependent	NULL
and	NULL
-independent	NULL
homotypic	NULL
adhesion	NULL
of	NULL
B	NULL
lymphocytes	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
22	NULL
:	NULL
147-152	NULL
,	NULL
1992	NULL
.	NULL

3	NULL
.	NULL

Alcover	NULL
,	NULL
A.	NULL
,	NULL
Juillard	NULL
,	NULL
V.	NULL
,	NULL
and	NULL
Acuto	NULL
,	NULL
0	NULL
.	NULL

Engagement	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
I	NULL
and	NULL
class	NULL
!	NULL

I	NULL
molecules	NULL
up-regulates	NULL
intercellular	NULL
adhesion	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
via	NULL
a	NULL
CD11/CD18-independent	NULL
mechanism	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
22	NULL
;	NULL
405-412	NULL
,	NULL
1992	NULL
.	NULL

4	NULL
.	NULL

Kabelitz	NULL
,	NULL
D.	NULL
,	NULL
and	NULL
Janssen	NULL
,	NULL
O	NULL
.	NULL

Growth	NULL
inhibition	NULL
of	NULL
Epstein-Barr	NULL
virus-transformed	NULL
B	NULL
cells	NULL
by	NULL
anti-HLA-DR	NULL
antibody	NULL
L243	NULL
:	NULL
possible	NULL
relationship	NULL
to	NULL
L243-induced	NULL
down-regulation	NULL
of	NULL
CD23	NULL
antigen	NULL
expression	NULL
.	NULL

Cell	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
120	NULL
:	NULL
21-30	NULL
,	NULL
1989	NULL
.	NULL

5	NULL
.	NULL

Mourad	NULL
,	NULL
W.	NULL
,	NULL
Scholl	NULL
,	NULL
P.	NULL
,	NULL
Diaz	NULL
,	NULL
A.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
,	NULL
and	NULL
Chatila	NULL
,	NULL
T.	NULL
The	NULL
staphylococcal	NULL
toxic	NULL
shock	NULL
syndrome	NULL
toxin	NULL
1	NULL
triggers	NULL
B	NULL
cell	NULL
proliferation	NULL
and	NULL
differentiation	NULL
via	NULL
major	NULL
histocompatibility	NULL
complex-unrestricted	NULL
cognate	NULL
T/B	NULL
cell	NULL
interaction	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
170	NULL
:	NULL
2011-2022	NULL
,	NULL
1989	NULL
.	NULL

6	NULL
.	NULL

Nabavi	NULL
,	NULL
N.	NULL
,	NULL
Freeman	NULL
,	NULL
G.	NULL
J.	NULL
,	NULL
Gault	NULL
,	NULL
A.	NULL
,	NULL
Godfrey	NULL
,	NULL
D.	NULL
,	NULL
Nadier	NULL
,	NULL
L.	NULL
M.	NULL
,	NULL
and	NULL
Glimcher	NULL
,	NULL
L.	NULL
H.	NULL
Signalling	NULL
through	NULL
the	NULL
MHC	NULL
class	NULL
iI	NULL
cytoplasmic	NULL
domain	NULL
is	NULL
required	NULL
for	NULL
antigen	NULL
presentation	NULL
and	NULL
induces	NULL
B7	NULL
expression	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
360	NULL
:	NULL
266-268	NULL
,	NULL
1992	NULL
.	NULL

7	NULL
.	NULL

Koutova	NULL
,	NULL
L.	NULL
,	NULL
Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
Shu	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Dupont	NULL
,	NULL
B	NULL
.	NULL

The	NULL
CD28	NULL
ligand	NULL
B7/BB1	NULL
provides	NULL
costimulatory	NULL
signal	NULL
for	NULL
alloactivation	NULL
of	NULL
CD4+	NULL
T	NULL
cells	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
173	NULL
:	NULL
759-762	NULL
,	NULL
1991	NULL
.	NULL

8	NULL
.	NULL

Aitomonte	NULL
,	NULL
M.	NULL
,	NULL
Pucillo	NULL
,	NULL
C.	NULL
,	NULL
Damante	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Maio	NULL
,	NULL
M.	NULL
Cross-linking	NULL
of	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
modulates	NULL
the	NULL
release	NULL
of	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
by	NULL
the	NULL
EBV-B	NULL
lymphoblastoid	NULL
cell	NULL
line	NULL
JY	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
151	NULL
:	NULL
5115-5122	NULL
,	NULL
1993	NULL
.	NULL

9	NULL
.	NULL

Law	NULL
,	NULL
C.	NULL
L.	NULL
,	NULL
and	NULL
Clark	NULL
,	NULL
E.	NULL
A.	NULL
Cell-cell	NULL
interactions	NULL
that	NULL
regulate	NULL
the	NULL
development	NULL
of	NULL
B-lineage	NULL
ceils	NULL
.	NULL

Curr	NULL
.	NULL

Opin	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
238-247	NULL
,	NULL
1994	NULL
.	NULL

10	NULL
.	NULL

Kincade	NULL
,	NULL
P.	NULL
W.	NULL
,	NULL
Lee	NULL
,	NULL
G.	NULL
,	NULL
Pietrangeli	NULL
,	NULL
C.	NULL
E.	NULL
,	NULL
Hayashi	NULL
,	NULL
S.	NULL
I.	NULL
,	NULL
and	NULL
Gimbie	NULL
,	NULL
J.	NULL
M.	NULL
Cells	NULL
and	NULL
molecules	NULL
that	NULL
regulate	NULL
B	NULL
lymphopoiesis	NULL
in	NULL
bone	NULL
marrow	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
7	NULL
:	NULL
111-143	NULL
,	NULL
1989	NULL
.	NULL

11	NULL
.	NULL

Kishimoto	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Hirano	NULL
,	NULL
T.	NULL
Molecular	NULL
regulation	NULL
of	NULL
B	NULL
lymphocyte	NULL
response	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
6	NULL
:	NULL
485-512	NULL
,	NULL
1988	NULL
.	NULL

12	NULL
.	NULL

Angel	NULL
,	NULL
P.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
The	NULL
role	NULL
of	NULL
Jun	NULL
,	NULL
Fos	NULL
and	NULL
AP-1	NULL
complex	NULL
in	NULL
.	NULL

cell-profiferation	NULL
and	NULL
transformation	NULL
.	NULL

Biochim	NULL
.	NULL

Biophys	NULL
.	NULL

Acta	NULL
,	NULL
1072	NULL
;	NULL
129-157	NULL
,	NULL
1991	NULL
.	NULL

13	NULL
.	NULL

Siebenlist	NULL
,	NULL
U.	NULL
,	NULL
Franzoso	NULL
,	NULL
G.	NULL
,	NULL
and	NULL
Brown	NULL
,	NULL
K.	NULL
Structure	NULL
,	NULL
regulation	NULL
and	NULL
function	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Cell	NULL
.	NULL

Biol	NULL
.	NULL

,	NULL
10	NULL
:	NULL
405-455	NULL
,	NULL
1994	NULL
.	NULL

14	NULL
.	NULL

Chauhan	NULL
,	NULL
D.	NULL
,	NULL
Kharbanda	NULL
,	NULL
S.	NULL
,	NULL
Uchiyama	NULL
,	NULL
H.	NULL
,	NULL
Urashima	NULL
,	NULL
M.	NULL
,	NULL
Fragoso	NULL
,	NULL
R.	NULL
,	NULL
Sen	NULL
,	NULL
J.	NULL
,	NULL
Kufe	NULL
,	NULL
D.	NULL
W.	NULL
,	NULL
and	NULL
Anderson	NULL
,	NULL
K.	NULL
C.	NULL
Identification	NULL
of	NULL
upstream	NULL
signals	NULL
regulating	NULL
interleukin-6	NULL
gene	NULL
expression	NULL
during	NULL
in	NULL
vitro	NULL
treatment	NULL
of	NULL
human	NULL
B	NULL
cells	NULL
with	NULL
pokeweed	NULL
mitogen	NULL
.	NULL

Blood	NULL
,	NULL
84	NULL
:	NULL
2243-2252	NULL
,	NULL
1994	NULL
.	NULL

15	NULL
.	NULL

Thing	NULL
,	NULL
K.	NULL
H.	NULL
,	NULL
Garewal	NULL
,	NULL
G.	NULL
,	NULL
Kearney	NULL
,	NULL
L.	NULL
,	NULL
Rassoo	NULL
!	NULL

,	NULL
F.	NULL
,	NULL
Melo	NULL
,	NULL
J.	NULL
V.	NULL
,	NULL
White	NULL
,	NULL
H.	NULL
,	NULL
Catovsky	NULL
,	NULL
D.	NULL
,	NULL
Foroni	NULL
,	NULL
L.	NULL
,	NULL
Luzzatto	NULL
,	NULL
L.	NULL
,	NULL
and	NULL
Goldman	NULL
,	NULL
J.	NULL
M.	NULL
Establishment	NULL
and	NULL
characterization	NULL
of	NULL
three	NULL
new	NULL
malignant	NULL
lymphoid	NULL
cell	NULL
lines	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
39	NULL
:	NULL
89-93	NULL
,	NULL
1987	NULL
.	NULL

16	NULL
.	NULL

Epstein	NULL
,	NULL
M.	NULL
A.	NULL
,	NULL
and	NULL
Barr	NULL
,	NULL
Y.	NULL
M.	NULL
Characteristics	NULL
and	NULL
mode	NULL
of	NULL
growth	NULL
of	NULL
a	NULL
tissue	NULL
culture	NULL
strain	NULL
(	NULL
EB1	NULL
)	NULL
of	NULL
human	NULL
lymphoblasts	NULL
from	NULL
Burkitt	NULL
's	NULL
lymphoma	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

(	NULL
Bethesda	NULL
)	NULL
,	NULL
34	NULL
:	NULL
231-240	NULL
,	NULL
1965	NULL
.	NULL

17	NULL
.	NULL

Hurwitz	NULL
,	NULL
R.	NULL
,	NULL
Hozier	NULL
,	NULL
J.	NULL
,	NULL
LeBien	NULL
,	NULL
T.	NULL
,	NULL
Minowada	NULL
,	NULL
J.	NULL
,	NULL
Gajl-Peczalska	NULL
,	NULL
K.	NULL
,	NULL
Kubonishi	NULL
,	NULL
I.	NULL
,	NULL
and	NULL
Kersey	NULL
,	NULL
J	NULL
.	NULL

Characterization	NULL
of	NULL
a	NULL
leukemic	NULL
cell	NULL
line	NULL
of	NULL
the	NULL
pre-B	NULL
phenotype	NULL
.	NULL

Int	NULL
.	NULL

J	NULL
.	NULL

Cancer	NULL
,	NULL
23	NULL
:	NULL
174-180	NULL
,	NULL
1979	NULL
.	NULL

18	NULL
.	NULL

Pegoraro	NULL
,	NULL
L.	NULL
,	NULL
Matera	NULL
,	NULL
L.	NULL
,	NULL
Ritz	NULL
,	NULL
J.	NULL
,	NULL
Levis	NULL
,	NULL
A.	NULL
,	NULL
Palumbo	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Biagini	NULL
,	NULL
G.	NULL
Establishment	NULL
of	NULL
a	NULL
Ph'-positive	NULL
human	NULL
cell	NULL
line	NULL
(	NULL
BV173	NULL
)	NULL
.	NULL

J.	NULL
Natl	NULL
.	NULL

Cancer	NULL
Inst	NULL
.	NULL

(	NULL
Bethesda	NULL
)	NULL
,	NULL
70	NULL
:	NULL
447-453	NULL
,	NULL
1983	NULL
.	NULL

19	NULL
.	NULL

Germain	NULL
,	NULL
R.	NULL
N.	NULL
,	NULL
and	NULL
Margulies	NULL
,	NULL
D.	NULL
H.	NULL
The	NULL
biochemistry	NULL
and	NULL
cell	NULL
biology	NULL
of	NULL
antigen	NULL
processing	NULL
and	NULL
presentation	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
17	NULL
:	NULL
403-450	NULL
,	NULL
1993	NULL
.	NULL

20	NULL
.	NULL

Lane	NULL
,	NULL
P.	NULL
J.	NULL
L.	NULL
,	NULL
McConnell	NULL
,	NULL
F.	NULL
M.	NULL
,	NULL
Schieven	NULL
,	NULL
G.	NULL
L.	NULL
,	NULL
Clark	NULL
,	NULL
E.	NULL
A.	NULL
,	NULL
and	NULL
Ledbetter	NULL
,	NULL
J	NULL
.	NULL

A	NULL
.	NULL

The	NULL
role	NULL
of	NULL
class	NULL
I	NULL
!	NULL

molecules	NULL
in	NULL
human	NULL
B	NULL
cell	NULL
activation	NULL
.	NULL

Association	NULL
with	NULL
phosphatidyl	NULL
inositol	NULL
turnover	NULL
,	NULL
protein	NULL
tyrosine	NULL
phospho-rylation	NULL
,	NULL
and	NULL
proliferation	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
144	NULL
:	NULL
3684-3692	NULL
,	NULL
1990	NULL
.	NULL

21	NULL
.	NULL

Mooney	NULL
,	NULL
N.	NULL
A.	NULL
,	NULL
Grillot-Courvalin	NULL
,	NULL
C.	NULL
,	NULL
Hivroz	NULL
,	NULL
C.	NULL
,	NULL
Ju	NULL
,	NULL
L.	NULL
Y.	NULL
,	NULL
and	NULL
Charron	NULL
,	NULL
D.	NULL
Early	NULL
biochemical	NULL
events	NULL
after	NULL
MHC	NULL
class	NULL
II-mediated	NULL
signaling	NULL
on	NULL
human	NULL
B	NULL
lymphocytes	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
145	NULL
;	NULL
2070-2076	NULL
,	NULL
1990	NULL
.	NULL

22	NULL
.	NULL

Trede	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Castigli	NULL
,	NULL
E.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Chatila	NULL
,	NULL
T.	NULL
Microbial	NULL
superantigens	NULL
induce	NULL
NF-kB	NULL
in	NULL
the	NULL
human	NULL
monocytic	NULL
cell	NULL
line	NULL
THP-1	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
150	NULL
;	NULL
5604-5613	NULL
,	NULL
1993	NULL
.	NULL

23	NULL
.	NULL

Mourad	NULL
,	NULL
W.	NULL
,	NULL
Mehindate	NULL
,	NULL
K.	NULL
,	NULL
Schall	NULL
,	NULL
T.	NULL
J.	NULL
,	NULL
and	NULL
McColl	NULL
,	NULL
S.	NULL
R.	NULL
Engagement	NULL
of	NULL
major	NULL
histocompatibility	NULL
complex	NULL
class	NULL
II	NULL
molecules	NULL
by	NULL
superan-tigen	NULL
induces	NULL
inflammatory	NULL
cytokine	NULL
gene	NULL
expression	NULL
in	NULL
human	NULL
rheuma-toid	NULL
fibroblast-like	NULL
synoviocytes	NULL
.	NULL

J.	NULL
Exp	NULL
.	NULL

Med	NULL
.	NULL

,	NULL
175	NULL
:	NULL
613-616	NULL
,	NULL
1992	NULL
.	NULL

24	NULL
.	NULL

Loken	NULL
,	NULL
M.	NULL
R.	NULL
,	NULL
Shah	NULL
,	NULL
V.	NULL
O.	NULL
,	NULL
Hollander	NULL
,	NULL
Z.	NULL
,	NULL
and	NULL
Civin	NULL
,	NULL
C.	NULL
I	NULL
.	NULL

Flow	NULL
cyto-metric	NULL
analysis	NULL
of	NULL
normal	NULL
B	NULL
lymphoid	NULL
development	NULL
.	NULL

Pathol	NULL
.	NULL

immuno-pathol	NULL
.	NULL

Res	NULL
.	NULL

,	NULL
7	NULL
:	NULL
357-370	NULL
,	NULL
1988	NULL
.	NULL

25	NULL
.	NULL

Foon	NULL
,	NULL
K.	NULL
A.	NULL
,	NULL
and	NULL
Todd	NULL
,	NULL
R.	NULL
F.	NULL
Immunologic	NULL
classification	NULL
of	NULL
leukemia	NULL
and	NULL
lymphoma	NULL
.	NULL

Blood	NULL
,	NULL
68	NULL
:	NULL
1-31	NULL
,	NULL
1986	NULL
.	NULL

26	NULL
.	NULL

Trede	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
,	NULL
and	NULL
Chatila	NULL
,	NULL
T.	NULL
Transcriptional	NULL
activation	NULL
of	NULL
IL-18	NULL
and	NULL
tumor	NULL
necrosis	NULL
factor-a	NULL
genes	NULL
by	NULL
MHC	NULL
class	NULL
II	NULL
ligands	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
146	NULL
:	NULL
2310-2315	NULL
,	NULL
1991	NULL
.	NULL

27	NULL
.	NULL

Beutier	NULL
,	NULL
B.	NULL
,	NULL
and	NULL
Cerami	NULL
,	NULL
A	NULL
.	NULL

The	NULL
biology	NULL
of	NULL
cachectin/TNF-A	NULL
primary	NULL
mediator	NULL
of	NULL
the	NULL
host	NULL
response	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
7	NULL
:	NULL
625-655	NULL
,	NULL
1989	NULL
.	NULL

28	NULL
.	NULL

Rubinstein	NULL
,	NULL
E.	NULL
,	NULL
Le	NULL
Naour	NULL
,	NULL
F.	NULL
,	NULL
Billard	NULL
,	NULL
M.	NULL
,	NULL
Prenant	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Boucheix	NULL
,	NULL
C.	NULL
CD9	NULL
antigen	NULL
is	NULL
an	NULL
accessory	NULL
subunit	NULL
of	NULL
the	NULL
VLA	NULL
integrin	NULL
complexes	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
24	NULL
:	NULL
3005-3013	NULL
,	NULL
1994	NULL
.	NULL

29	NULL
.	NULL

Fujita	NULL
,	NULL
K.	NULL
,	NULL
Imoto	NULL
,	NULL
S.	NULL
,	NULL
Phuchareon	NULL
,	NULL
J.	NULL
,	NULL
and	NULL
Tokuhisa	NULL
,	NULL
T.	NULL
c-fos	NULL
and	NULL
jun	NULL
gene	NULL
expression	NULL
in	NULL
murine	NULL
precursor	NULL
B	NULL
lymphocytes	NULL
developed	NULL
in	NULL
the	NULL
interleukin-7-dependent	NULL
bone	NULL
marrow	NULL
cell	NULL
culture	NULL
.	NULL

Immunobiology	NULL
,	NULL
190	NULL
;	NULL
13-22	NULL
,	NULL
1994	NULL
.	NULL

30	NULL
.	NULL

Basuerie	NULL
,	NULL
P.	NULL
A.	NULL
,	NULL
and	NULL
Henkel	NULL
,	NULL
T.	NULL
Function	NULL
and	NULL
activation	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
in	NULL
the	NULL
immune	NULL
system	NULL
.	NULL

Annu	NULL
.	NULL

Rev	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
12	NULL
;	NULL
141-179	NULL
,	NULL
1994	NULL
.	NULL

31	NULL
.	NULL

Lenardo	NULL
,	NULL
M.	NULL
J.	NULL
,	NULL
and	NULL
Baltimore	NULL
,	NULL
D.	NULL
NF-	NULL
«	NULL
B	NULL
:	NULL
a	NULL
pleiotropic	NULL
mediator	NULL
of	NULL
inducible	NULL
and	NULL
tissue-specific	NULL
gene	NULL
control	NULL
.	NULL

Cell	NULL
,	NULL
58	NULL
:	NULL
227-229	NULL
,	NULL
1989	NULL
.	NULL

32	NULL
.	NULL

Brenner	NULL
,	NULL
D.	NULL
A.	NULL
,	NULL
O'Hara	NULL
,	NULL
M.	NULL
,	NULL
Angel	NULL
,	NULL
P.	NULL
,	NULL
Chojkier	NULL
,	NULL
M.	NULL
,	NULL
and	NULL
Karin	NULL
,	NULL
M.	NULL
Prolonged	NULL
activation	NULL
of	NULL
jun	NULL
and	NULL
collagenase	NULL
genes	NULL
by	NULL
tumor	NULL
necrosis	NULL
factor-	NULL
«	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
337	NULL
:	NULL
661-663	NULL
,	NULL
1989	NULL
.	NULL

33	NULL
.	NULL

Leonardi	NULL
,	NULL
A.	NULL
,	NULL
Altomonte	NULL
,	NULL
M.	NULL
,	NULL
Maio	NULL
,	NULL
M.	NULL
,	NULL
Tell	NULL
,	NULL
G.	NULL
,	NULL
Bearz	NULL
,	NULL
A.	NULL
,	NULL
Formisano	NULL
,	NULL
S.	NULL
,	NULL
and	NULL
Pucillo	NULL
,	NULL
C.	NULL
Biphasic	NULL
control	NULL
of	NULL
NF-	NULL
«	NULL
B	NULL
activation	NULL
induced	NULL
by	NULL
the	NULL
triggering	NULL
of	NULL
HLA-DR	NULL
antigens	NULL
expressed	NULL
on	NULL
B	NULL
cells	NULL
.	NULL

Cytokine	NULL
,	NULL
in	NULL
press	NULL
,	NULL
1997	NULL
.	NULL

34	NULL
.	NULL

Dellabona	NULL
,	NULL
P.	NULL
,	NULL
Peccoud	NULL
,	NULL
J.	NULL
,	NULL
Kappler	NULL
,	NULL
J.	NULL
,	NULL
Marrack	NULL
,	NULL
P.	NULL
,	NULL
Benoist	NULL
,	NULL
C.	NULL
,	NULL
and	NULL
Mathis	NULL
,	NULL
D.	NULL
Superantigens	NULL
interact	NULL
with	NULL
MHC	NULL
class	NULL
II	NULL
molecules	NULL
outside	NULL
of	NULL
the	NULL
antigen	NULL
groove	NULL
.	NULL

Cell	NULL
,	NULL
62	NULL
:	NULL
1115-1121	NULL
,	NULL
1990	NULL
.	NULL

35	NULL
.	NULL

Trede	NULL
,	NULL
N.	NULL
S.	NULL
,	NULL
Chatita	NULL
,	NULL
T.	NULL
,	NULL
and	NULL
Geha	NULL
,	NULL
R.	NULL
S.	NULL
Activator	NULL
protein-1	NULL
(	NULL
AP-1	NULL
)	NULL
is	NULL
stimulated	NULL
by	NULL
microbial	NULL
superantigens	NULL
in	NULL
human	NULL
monocytic	NULL
cells	NULL
.	NULL

Eur	NULL
.	NULL

J	NULL
.	NULL

Immunol	NULL
.	NULL

,	NULL
23	NULL
:	NULL
2129-2135	NULL
,	NULL
1993	NULL
.	NULL

36	NULL
.	NULL

Altomonte	NULL
,	NULL
M.	NULL
,	NULL
Simonelli	NULL
,	NULL
C.	NULL
,	NULL
Tirelli	NULL
,	NULL
U.	NULL
,	NULL
and	NULL
Maio	NULL
,	NULL
M.	NULL
Signaling	NULL
by	NULL
HLA	NULL
class	NULL
II	NULL
antigens	NULL
on	NULL
B	NULL
cells	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
16	NULL
:	NULL
548	NULL
,	NULL
1995	NULL
.	NULL

37	NULL
.	NULL

Sakihama	NULL
,	NULL
T.	NULL
,	NULL
Smolyar	NULL
,	NULL
A.	NULL
,	NULL
and	NULL
Reinherz	NULL
,	NULL
E.	NULL
L.	NULL
Molecular	NULL
recognition	NULL
of	NULL
antigen	NULL
invoives	NULL
lattice	NULL
formation	NULL
between	NULL
CD4	NULL
,	NULL
MHC	NULL
class	NULL
II	NULL
and	NULL
TCR	NULL
molecules	NULL
.	NULL

Immunol	NULL
.	NULL

Today	NULL
,	NULL
16	NULL
:	NULL
581-587	NULL
,	NULL
1995	NULL
.	NULL

38	NULL
.	NULL

Matsumoto	NULL
,	NULL
M.	NULL
,	NULL
Mariathasan	NULL
,	NULL
S.	NULL
,	NULL
Nahm	NULL
,	NULL
M.	NULL
H.	NULL
,	NULL
Baranyay	NULL
,	NULL
F.	NULL
,	NULL
Pe-schon	NULL
,	NULL
J.	NULL
J.	NULL
,	NULL
and	NULL
Chaplin	NULL
,	NULL
D.	NULL
D.	NULL
Role	NULL
of	NULL
lymphotoxin	NULL
and	NULL
the	NULL
type	NULL
|	NULL
TNF	NULL
receptor	NULL
in	NULL
the	NULL
formation	NULL
of	NULL
germinal	NULL
centers	NULL
.	NULL

Science	NULL
(	NULL
Washington	NULL
DC	NULL
)	NULL
,	NULL
271	NULL
:	NULL
1289-1290	NULL
.	NULL

39	NULL
.	NULL

Gruss	NULL
,	NULL
H.	NULL
J.	NULL
,	NULL
and	NULL
Dower	NULL
,	NULL
S.	NULL
K.	NULL
Tumor	NULL
necrosis	NULL
factor	NULL
ligand	NULL
super-family	NULL
:	NULL
involvement	NULL
in	NULL
the	NULL
pathology	NULL
of	NULL
malignant	NULL
lymphomas	NULL
.	NULL

Blood	NULL
,	NULL
85	NULL
:	NULL
3378-3404	NULL
,	NULL
1995	NULL
.	NULL

40	NULL
.	NULL

Laemmli	NULL
,	NULL
U.	NULL
K.	NULL
Cleavage	NULL
of	NULL
structural	NULL
proteins	NULL
during	NULL
the	NULL
assembly	NULL
of	NULL
the	NULL
head	NULL
of	NULL
bacteriophage	NULL
T4	NULL
.	NULL

Nature	NULL
(	NULL
Lond	NULL
.	NULL
)	NULL

,	NULL
227	NULL
:	NULL
680-685	NULL
,	NULL
1970	NULL
.	NULL

41	NULL
.	NULL

Sambrook	NULL
,	NULL
J.	NULL
,	NULL
Fritsch	NULL
,	NULL
E.	NULL
F.	NULL
,	NULL
and	NULL
Maniatis	NULL
,	NULL
T	NULL
.	NULL

(	NULL
eds	NULL
.	NULL
)	NULL

.	NULL

Molecular	NULL
Clon-ing	NULL
:	NULL
A	NULL
Laboratory	NULL
Manual	NULL
.	NULL

Cold	NULL
Spring	NULL
Harbor	NULL
,	NULL
NY	NULL
:	NULL
Cold	NULL
Spring	NULL
Harbor	NULL
Laboratory	NULL
,	NULL
1989	NULL
.	NULL

